WO2015111554A1 - Tear duct tube - Google Patents

Tear duct tube Download PDF

Info

Publication number
WO2015111554A1
WO2015111554A1 PCT/JP2015/051275 JP2015051275W WO2015111554A1 WO 2015111554 A1 WO2015111554 A1 WO 2015111554A1 JP 2015051275 W JP2015051275 W JP 2015051275W WO 2015111554 A1 WO2015111554 A1 WO 2015111554A1
Authority
WO
WIPO (PCT)
Prior art keywords
lacrimal
tube
tubular member
colored portion
colored
Prior art date
Application number
PCT/JP2015/051275
Other languages
French (fr)
Japanese (ja)
Inventor
千尋 古賀
荻野 英司
文康 平井
深谷 浩平
偉一 宮内
真梨子 松本
Original Assignee
株式会社カネカ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社カネカ filed Critical 株式会社カネカ
Priority to JP2015558846A priority Critical patent/JP6581909B2/en
Publication of WO2015111554A1 publication Critical patent/WO2015111554A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/00772Apparatus for restoration of tear ducts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/005Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in colour

Definitions

  • the present invention relates to a lacrimal tube used for lacrimal passage obstruction treatment.
  • lacrimal passage obstruction leading to lacrimation For treatment of lacrimal passage obstruction leading to lacrimation, (i) probing with lacrimal passage bougie, (ii) placement of lacrimal duct tube, (iii) lacrimal nasal sinus anastomosis (DCR), (iv) lacrimal tubuloplasty , (V) nasolacrimal duct arthroplasty, (vi) lacrimal cone movement.
  • the probing by the lacrimal passage bougie (i) described above is to open the occluded site by inserting a capillary tube called a bougie into the lacrimal passage and reconstruct the tear fluid flow path.
  • the (ii) lacrimal tube used later is an intra lacrimal intubation device that is placed in order to maintain the flow path and reconstruct the tissue. Since these treatments are easy and minimally invasive, they are often performed as the first treatment.
  • the lacrimal tube used in (ii) is placed in order to maintain the flow path and reconstruct the tissue after probing with the lacrimal bougie in (i).
  • the placement of the lacrimal duct tube of (ii) is easier, less invasive and more effective than the treatment methods (iii) to (vi) described above.
  • a lacrimal duct tube is formed of a thin and soft tube or rod at the center of the tube, and a hard and thick tube on both sides thereof (see, for example, Patent Documents 1, 2, and 3). ) Is widely spread.
  • the lacrimal duct tube consists of a tube and a pair of bougies inserted from the cuts on both sides of the tube, and the bougie is operated to guide the tube into the lacrimal tract and place it.
  • the lacrimal passage is composed of the punctum (21, 22), lacrimal canal (23, 24), lacrimal sac (26), nasolacrimal duct (27), and the like.
  • a lacrimal tube is inserted into the lacrimal passage.
  • the operation inside the lacrimal passage using a bougie must be performed in a groping state that relies on the sense of the operator's fingertips, and the operator has advanced operation technology. Otherwise, the bougie may break through the tube or make a hole other than the normal lacrimal tract (temporary tract), in which case the treatment results were poor.
  • a Teflon (registered trademark) or polyurethane outer sheath covering the lacrimal endoscope is inserted into the punctum before the lacrimal endoscope, and the inside of the lacrimal passage is observed with the lacrimal endoscope
  • the occlusion portion is punctured, and then the insertion is performed until the sheath tip comes out from the opening of the nasolacrimal duct, and then only the lacrimal endoscope is removed while leaving the sheath.
  • a sheath 30 attached to the lacrimal endoscope 29 is blocked by the lower nasal passage 28 of the lacrimal passage 31 from the upper punctum 21 through the upper lacrimal tubule 23.
  • the lacrimal tube is connected to the end of the punctum-side sheath inserted in the SEP, and the sheath tip that has come out of the occluded portion is pinched with forceps under nasal endoscopy.
  • the lacrimal duct tube is pulled by the sheath and inserted into the space of the closed portion opened by SEP. Thereafter, the connection between the sheath and the lacrimal duct tube is removed, and the placement is completed.
  • the lacrimal tube 33 is connected to the sheath 30 as shown in FIG. 2 (a), and the sheath 30 is connected to the side opposite to the side where the lacrimal tube 33 is connected as shown in FIG. 2 (b).
  • the lacrimal duct tube 33 is inserted into the lacrimal passage 31 to penetrate the occlusion site 32.
  • the sheath 30 is removed and the lacrimal tube 33 is placed in the lacrimal passage 31.
  • another sheath 30 attached to the lacrimal endoscope 29 is located in the lower nasal passage 28 of the lacrimal passage 31 from the lower lacrimal point 22 where the lacrimal passage tube 33 is not inserted, through the lower lacrimal tubule 24.
  • the lacrimal endoscope 29 is removed, and the end of the lacrimal tube 33 that does not penetrate the occlusion site 32 is connected to the sheath 30,
  • the sheath 30 is pulled from the side opposite to the side where the lacrimal tube 33 is connected to penetrate the other end of the lacrimal tube 33, and finally the sheath 30 is removed, as shown in FIG.
  • the canal tube 33 is placed in the lacrimal passage 31.
  • the insertion method combining the SEP and SGI is not a blind method as in the prior art, but is an excellent safety method in that the puncture of the occlusion can be performed under a lacrimal endoscope.
  • the sheath used for SEP is made of a highly rigid material, the manipulation from the hand and the force can be transmitted directly to the tip for fine manipulation, and the lacrimal endoscope can be broken during the operation. There is an advantage that there is little risk that the tip fiber is broken.
  • the object of the present invention is to provide a lacrimal tube that can be suitably used for the treatment of lacrimal passage obstruction similar to SEP, specifically, when performing a procedure by attaching to a lacrimal endoscope. Easily confirm your own tip position and lacrimal tract occlusion, and easily and safely treat lacrimal tract occlusion by using a portion of the lacrimal tube inserted and indwelled at the time of insertion later. To provide a lacrimal tube.
  • the present inventors have intensively studied to solve such problems. As a result, paying attention to the end portion at one end of the tube-shaped member constituting the lacrimal tube, and providing a colored portion at the end portion, the lacrimal tube is surely placed at a desired position even when operated in the dark lacrimal passage Has been found to be able to be inserted, and the present invention has been completed.
  • the gist of the present invention is as follows.
  • a lacrimal duct tube comprising a pair of tubular members having an opening communicating with the lumen at one end, and a connecting member connecting the other ends of the tubular members, A terminal portion including one end of at least one of the tubular members is formed of a colorless material, A colored portion along the longitudinal direction of the tubular member is formed on a part of the periphery of the end portion formed of the colorless material, A lacrimal duct tube, wherein a hue of one tube-shaped member of the pair of tube-shaped members is a complementary color hue or an adjacent complementary color hue with respect to the hue of the colored portion in a hue ring.
  • the colored portion in the tubular member is formed on the same side as the position of the entrance / exit on the other end side of the tubular member in the circumferential direction of the tubular member and at least one side opposite to the position.
  • the lacrimal duct tube according to any one of [1] to [4].
  • the colored portion is formed on the same side as the position of the entrance / exit in the circumferential direction of the tubular member and on the opposite side, and the width of one colored portion is different from the width of the other colored portion.
  • the colored portion having a narrow width is formed on the same side as the position of the entrance / exit in the circumferential direction of the tubular member, and the colored portion having a large width is formed on the opposite side.
  • the distal end portion including one end of at least one of the tubular members is formed of a colorless material, so that the lacrimal duct endoscope is inserted into the lacrimal duct tube during the procedure. Can be ensured. Further, by forming a colored portion along the longitudinal direction of the tubular member in a part of the periphery of the distal portion formed of the colorless material, the distal portion of the distal portion can be observed under the observation of the lacrimal endoscope during the procedure. The position can be easily confirmed.
  • the tube inserted in the dark environment in the lacrimal passage is that the hue of the tube-shaped member of the lacrimal passage tube of the present invention is a complementary hue or an adjacent complementary hue with respect to the hue of the colored portion in the hue ring The specific position of the member can be easily confirmed.
  • the lacrimal passage referred to in the present invention is the upper / lower punctum (21/22), upper / lower lacrimal duct (23/24), total lacrimal duct (25), lacrimal sac (26) , Lacrimal duct (27), nasal duct (not shown), Hasner's valve (not shown), and tears produced from the lacrimal gland (not shown) are transferred from the ocular surface to the lower nasal passage (28 ) Is a tube (eyeball appendage) that leads to FIG. 3 schematically shows the anatomical structure of the lacrimal passage.
  • the tube leading from the upper punctum (21) to the lower nasal passage (28) through the upper lacrimal canal (23) and the total lacrimal canal (25) is called the upper lacrimal passage.
  • the duct leading to the lower nasal passage (28) through the lacrimal canal (24) and the total lacrimal duct (25) is called the lower lacrimal passage.
  • the lacrimal tube of the present invention is a lacrimal tube including a pair of tubular members having an opening communicating with the lumen at one end, and a connecting member connecting the other ends of the tubular members, A terminal portion including one end of at least one of the tubular members is formed of a colorless material, A colored portion along the longitudinal direction of the tubular member is formed on a part of the periphery of the end portion formed of the colorless material, The hue of one tubular member of the pair of tubular members is a complementary color hue or an adjacent complementary hue with respect to the hue of the colored portion in a hue ring.
  • the structure of the tubular member may be an integrated tube made of the same resin composition, a laminated structure in which a plurality of layers of different types of resin are laminated in the thickness direction, or a plurality of tubes of different types of resin May be a tube having a row structure in which are connected in the longitudinal direction.
  • the resin constituting the tubular member is not particularly limited, and examples thereof include polyethylene, silicone, polyamide elastomer, polyurethane, isobutylene copolymers, and resin compositions containing these alloys. It is not limited.
  • the alloy is not particularly limited.
  • the isobutylene block copolymer (A), the thermoplastic polyurethane resin (B), and The hardness of the tube can be adjusted by adjusting the ratio. The greater the ratio of the thermoplastic polyurethane resin (B), the greater the hardness of the tube.
  • the resin composition for an integral tube used in the present invention may be composed of only the isobutylene block copolymer (A) and the thermoplastic polyurethane resin (B), but may be mixed with other components.
  • SIBS styrene-isobutylene-styrene block copolymer
  • thermoplastic polyurethane resin (B) (hereinafter sometimes referred to as TPU), “Milactolan E385PNAT” manufactured by Nippon Milactolan, which is an ether type aromatic cyclic polyurethane, “Tecotan TT1074A” manufactured by Lubrizol, or ether type alicyclic type “Tecoflex EG100A” and “Tecoflex EG85A” manufactured by Lubrizol, which are polyurethanes, and “Calbutton PC3575A” manufactured by Lubrizol, which is a polycarbonate-based polyurethane, are preferable.
  • the resin used for each layer may be changed.
  • the inner layer it is preferable to use polyethylene as a highly rigid resin in order to improve the pushability of the lacrimal duct tube during insertion.
  • polyurethane it is preferable to use polyurethane as a softer resin for the outer layer in the portion that contacts the lacrimal passage.
  • the laminated structure has three layers, polyurethane is used for the outermost layer, adhesive polyethylene is used for the intermediate layer, and high-rigidity polyethylene is used for the innermost layer. Therefore, there is an advantage that the pushability can be obtained and the safety when operated in the lacrimal passage is excellent.
  • each layer is welded over the entire long axis direction of the tube-shaped member, so that the continuity of rigidity is maintained, kink hardly occurs, and the force is easily transmitted from the other end side to the one end side when inserting the lacrimal tube. There is an advantage that it is excellent in operability.
  • the lumen of the tubular member serves as a space for accommodating the lacrimal endoscope inserted from the entrance provided at the proximal end of the tubular member, and the lacrimal passage
  • the tube When the tube is placed in the lacrimal passage, it becomes a flow path for bodily fluids such as tears through an entrance provided at the proximal end of the tubular member.
  • the opening at one end of the tubular member becomes a part of a flow path for bodily fluids such as tears when the lacrimal tube is indwelled, and of the lacrimal endoscope inserted from the entrance / exit provided at the base end.
  • bodily fluids such as tears
  • the tip is inserted to the vicinity of the opening, the visual field from the lacrimal endoscope is secured through the opening, the tube forms a temporary path, and the mucous membrane is damaged, causing bleeding, etc. Can avoid problems.
  • the outer diameter of the tube-shaped member may be in a range that can be inserted into the lacrimal passage. For example, if the maximum outer diameter is 0.8 mm or more and 1.7 mm or less, regardless of the difference in nationality and gender. Can handle a wide range of patient lacrimal passages.
  • the length of the tubular member is not particularly limited as long as it is about the same as a commercially available lacrimal duct tube.
  • the tubular member has an inlet / outlet communicating with the lumen of the tubular member on the other end side connected to the connecting member.
  • the entrance / exit is not only an entrance / exit for inserting / extracting a lacrimal passage manipulator such as a lacrimal endoscope, but also an entrance / exit of a body fluid such as a tear when the lacrimal tube is placed in the lacrimal passage.
  • the entrance / exit may be formed on the wall of the tubular member, or may be formed on the proximal end of the tubular member by, for example, obliquely cutting the tubular proximal end toward the connecting member. Also good. There is no particular limitation on the shape and area of the entrance / exit.
  • the lacrimal duct tube of the present invention has one feature in that a terminal portion including one end of at least one of the tubular members is formed of a colorless material.
  • the lacrimal endoscope is provided. In a state of being inserted into the lacrimal duct tube, not only from the opening of the tubular member but also from the wall surface of the tubular member, it is possible to observe the external state with a lacrimal endoscope.
  • the colorless material constituting the end portion includes a transparent material having no color at all, and even if there is a color derived from the constituent resin, it passes through the wall from the lacrimal duct endoscope in the lumen.
  • a material transparent to such an extent that an external state can be observed for example, translucent blue is also included.
  • the total length of the end portion is not particularly limited, and may be in the range of 2 to 10 mm from one end.
  • At least one tubular member is formed with one or more colored portions along the major axis direction of the tubular member around a part of the end portion formed of the colorless material.
  • this feature also has a feature. It becomes possible to confirm the position of the end portion during the procedure. When the colored portion is further formed to one end of the tubular member, it can be confirmed to the position of one end of the tubular member in the lacrimal passage during the procedure.
  • the shape of the colored portion is not particularly limited, but it is a series of lines or broken lines, so that the position and state of the distal end portion of the tubular member can be determined by the lacrimal endoscope located in the lumen of the tubular member. Therefore, there is an advantage that it is easy to observe and grasp from, and accurate lacrimal tube insertion can be performed.
  • the colored portion has a width of 1/50 or more and 1/3 or less of the total peripheral length of the end portion, the position and state of the end portion of the tubular member inserted into the lacrimal passage during the procedure It becomes easier to observe and grasp from the lacrimal endoscope in the lumen of the tubular member.
  • the width of the colored part is more preferably 1/20 or more and 1/5 or less.
  • the position of the colored portion in the tubular member is not particularly limited, and for example, the same side as the position of the entrance and exit in the circumferential direction with reference to the position of the entrance and exit provided on the other end side of the tubular member and If formed on at least one side of the opposite side, the direction of the distal end can also be confirmed from the position of the colored portion that can be observed from the lacrimal endoscope and the position of the entrance / exit of the proximal end.
  • the terminal part when the colored part is formed on the same side as the position of the entrance / exit in the circumferential direction of the tubular member and on the opposite side, even if the terminal part is deformed when the closed part in the lacrimal passage is pierced, the terminal part It is possible to accurately grasp the deformed state and the positional relationship between the opening and the lacrimal endoscope. Furthermore, changing the width of the plurality of colored portions, for example, the narrow colored portion (thin colored portion) is formed on the same side as the position of the entrance / exit in the circumferential direction of the tubular member, and has a large width.
  • the colored portion (wide colored portion) is formed on the opposite side, the direction of the lacrimal tube can be confirmed, and the lacrimal tube is surely inserted into the target place without making a mistake in the direction. Becomes easier.
  • the wide colored portion is formed on the same side as the position of the entrance / exit in the circumferential direction of the tubular member and the narrow colored portion is formed on the opposite side, the same effect as described above is obtained.
  • the orientation of the entrance / exit, and hence the lacrimal duct tube can be grasped relatively easily, and accurate insertion Easy to use.
  • the specific color of the colored portion there is no particular limitation on the specific color of the colored portion, but since the inside of the nasal cavity is generally red, red and complementary colors or adjacent complementary colors are used in the hue circle so that the eyes can be easily confirmed through the lacrimal endoscope. What is necessary is just to adjust to the color used as a hue relationship, for example, blue, cyan, etc. are mentioned.
  • the colored portion may be provided at the end portion of at least one tubular member, or the colored portion may be provided at the end portions of the two tubular members.
  • the color of each colored part may be the same or different.
  • a series of line or broken line colored portions are provided, and when there are a plurality of the lines, the colors of the lines may be the same or different.
  • the hue of one tube-shaped member of the pair of tube-shaped members is a complementary color hue or an adjacent complementary color hue with respect to the hue of the colored portion in the hue ring, The specific position of the tubular member inserted in the dark environment can be easily confirmed.
  • the entire periphery of the tubular member on the other end side from the colored portion may be colored.
  • a procedure using a conventional sheath it is difficult to insert a sheath into a lacrimal passage that is dark and obstructed with an intricate shape, even if a lacrimal endoscope is used.
  • the entire periphery of the tube-shaped member on the other end side is colored from the colored portion, the position of the tube-shaped member previously inserted into the lacrimal passage is inserted into the tube shape later. It can be confirmed from the lacrimal endoscope in the member, and it can be used as a guide to perform accurate insertion. Therefore, the formation of a temporary road can be prevented.
  • the color of the tubular member on the other end side from the colored portion it may be adjusted so that it becomes a complementary hue or an adjacent complementary hue with respect to the hue of the colored portion in the hue ring, for example, yellow, yellow-green, Examples include green.
  • the color of the colored portion is blue and the color of the colored tubular member on the other end side is yellow.
  • the colored part may be produced by a method such as line extrusion tube molding using a mold or heat welding a solid tube colored at a desired position of a tubular member, and the production method is particularly limited. Not.
  • the tube-shaped member on the other end side from the colored portion may be colored on at least one tube-shaped member, or may be applied to each of the two tube-shaped members.
  • each color may be the same or different.
  • the tube-shaped member when confirming the position of the tube-shaped member previously inserted in the lacrimal passage through the lacrimal endoscope from the inside of the tube-shaped member inserted later
  • the color of the tubular member previously placed with respect to the inner surface of the nasal cavity is conspicuous. That is, the tubular member can be confirmed more clearly in the dark lacrimal passage, and the positional accuracy of the tubular member to be placed later can be increased.
  • the tube-shaped member may be used even if there is no colored portion at the end. Examples of such colors include yellow, yellowish green, and green.
  • the colored part is eliminated by making the end part not transparent and colorless, but by using a transparent material (for example, translucent blue) that allows the external appearance to be observed from the lacrimal endoscope through the wall of the end part.
  • a transparent material for example, translucent blue
  • the position of the tubular member previously inserted into the lacrimal passage is inserted later from within the tubular member. Since it can be confirmed through the lacrimal endoscope (for example, from the end portion), the tubular member can be more clearly confirmed even in the dark lacrimal passage, and the positional accuracy of the tubular member to be placed later can be improved.
  • the connecting member is for connecting the other ends of the two tubular members and may have a diameter smaller than that of the tubular member, and the diameter is not particularly limited.
  • the resin constituting the connecting member may be a flexible resin, and examples thereof include a resin composition containing silicone, polyamide elastomer, polyurethane, isobutylene copolymer, and alloys thereof. However, it is not limited to these.
  • the length of the connecting member is not particularly limited as long as it is about the same as a commercially available lacrimal duct tube.
  • the way of connecting the tubular member and the connecting member is not particularly limited.
  • the end of the other end side of the tubular member and the end of the connecting member may be in contact with each other, or from the viewpoint of increasing the connecting surface and increasing the strength of the connecting portion, You may be connected by the side surface of the base end part of a member, and the side surface of the said connection member.
  • the lacrimal tube of the present invention may be provided with a hydrophilic coating on the surface of the tubular member or the connecting member from the viewpoint of excellent insertion into the lacrimal passage and operability in the lacrimal passage. .
  • the hydrophilic coating used for the hydrophilic coating portion expresses lubricity when it comes into contact with blood or tears, reduces resistance when the lacrimal passage is inserted, and realizes suitable operability in the lacrimal passage Is.
  • the type of hydrophilic coating is not particularly limited, and hydrophilic polymers such as poly (2-hydroxyethyl methacrylate), polyacrylamide, polyvinyl pyrrolidone, polyalkylene glycol, monomethoxy polyalkylene glycol, or blends thereof are preferably used. Is done.
  • the lacrimal endoscope used in the present invention is not particularly limited as long as it can be used for treatment of lacrimal passage obstruction.
  • a lacrimal tube operating tool other than the lacrimal endoscope can be used.
  • an operating rod such as a bougie is cited.
  • 4 (a), 4 (b), and 4 (c) show an example of the appearance of the lacrimal duct tube 1 of the present invention.
  • 4A is a perspective view of the lacrimal tube 1
  • FIG. 4B is a side view of the lacrimal tube 1
  • FIG. 4C is a top view of the lacrimal tube 1.
  • the lacrimal duct tube 1 is a lacrimal duct tube including a pair of tubular members 2 and a connecting member 3 that connects the ends of the tubular members 2.
  • Each of the tubular members 2 has an opening 5 at one end (tip) 4, and the opening 5 communicates with the lumen 6.
  • the pair of tubular members 2 are both connected to the connecting member 3 on the other end side 7.
  • the tubular member 2 is composed of a distal end portion 8, a main body 9, and a proximal end portion 10 from one end 4 to the other end 7. have.
  • At least one end portion 8 including the one end 4 of the tubular member 2 is formed of a colorless material.
  • the total length of the end portion 8 is not particularly limited, and may be in the range of 2 to 10 mm from the one end 4.
  • a colored portion (line) 12 is formed along the long axis direction of the tubular member around a part of the end portion 8 formed of the colorless material.
  • the colored portion 12 is provided on the opposite side of the entrance / exit 11 with respect to the circumferential direction of the tubular member, and therefore is in a position that cannot be seen in the side view of FIG. 4 (b).
  • the colored portion 12 may be formed up to one end 4 of the tubular member 2 as shown in FIGS. 4A and 4C, or may be shorter.
  • the shape of the colored portion 12 may be a series of lines as shown in FIGS. 4 (a) and 4 (c), or may be a broken line as shown in FIGS. 5 (a) and 5 (b).
  • FIG. 5B is an enlarged view of the vicinity of the end portion 8 of the tubular member 2 of FIG.
  • the width of the colored portion 12 may be a width of 1/50 or more and 1/3 or less with respect to the entire peripheral length of the end portion 8. For example, as shown in FIGS. 6 (a) and 6 (b), even if the width is 1/3 of the entire peripheral length of the end portion 8, the inside of the lacrimal passage through the transparent wall portion other than the colored portion 12 is used. Confirmation is possible.
  • FIG.6 (b) is an enlarged view of the terminal part 8 vicinity of the tubular member 2 of Fig.6 (a).
  • the colored portion 12 may be formed on the same side as the position of the entrance / exit 11 in the circumferential direction of the tubular member 2 and on at least one side opposite to the side.
  • the position of the narrowest portion (the other end 7) of the tapered shape of the base end portion 10 which is eccentric with respect to the center of the base end portion 10 of the tubular member 2 or the main body 9 is the position of the entrance / exit 11. It may be on the opposite side of the position.
  • the colored portion 12 is formed on the side opposite to the position of the entrance / exit 11 in the circumferential direction of the tubular member 2. Further, in FIGS.
  • the colored portion 12 is formed on the same side as the position of the entrance / exit 11 in the circumferential direction of the tubular member 2.
  • the two colored parts 12a and 12b may be formed in the same side as the position of the entrance / exit 11 in the circumferential direction of the tubular member 2, and an opposite side. In this case, for example, as shown in FIG.
  • the width of the colored portion 12a on the same side as the position of the entrance / exit 11 is preferably different from the width of the colored portion 12b on the side opposite to the position of the entrance / exit 11 (
  • the present invention is not limited to this, and the arrangement of the colored portions 12a and 12b having different widths may be reversed, or the colored portions 12a and 12b having the same width may be formed.
  • the deformation state of the end portion 8 can be grasped three-dimensionally, the position of the opening 5 can be grasped by the lacrimal endoscope, and the tip position of the lacrimal endoscope can be grasped. Further, the orientation of the lacrimal tube can also be grasped from the positional relationship between the colored portions 12a and 12b having different widths and the entrance / exit 11. These allow accurate lacrimal tube insertion.
  • another colored portion 13 is provided around the entire circumference of the tubular member 2 on the other end side from the colored portion 12.
  • the colored portion 13 may be formed at least on the main body 9 of the tubular member 2 as shown in FIGS. 4 (a) to 4 (c), but may also be formed on the base end portion 10. .
  • the colored portion 13 may be on one side of the tubular member 2.
  • the lacrimal tube 1 shown in FIGS. 9 (a) to 9 (c) has the same configuration as the lacrimal tube 1 shown in FIGS. 4 (a) to 4 (c) except that the two colored portions 13 are provided. Is the same.
  • the hue of the colored portion 13 is a complementary hue or an adjacent complementary hue with respect to the hue of the colored portion 12 in a hue circle. Especially, since the color of the colored portion 13 is yellow and the color of the colored portion 12 is blue, the position of the tubular member 2 can be easily confirmed in the dark lacrimal passage. Moreover, when the colored part 13 is given to the two tubular members 2 like the lacrimal duct tube 1 shown to FIG. 9 (a), (c), the color of one colored part 13 is changed. Yellow, yellow-green, or green may be used, and the color of the other colored portion 13 may be the same as or different from the color described above.
  • the entrance / exit 11 is provided at the end on the other end side of the tubular member as shown in FIGS. 4 (a), 5 (a), and 6 (a).
  • FIG. For example, you may provide a hole in the arbitrary wall part of the main body 9 of the tubular member 2 of FIG.4 (c) (not shown).
  • the shape of the hole is not particularly limited, but an elliptical shape is preferable.
  • the lacrimal duct tube 1 shown to Fig.5 (a), FIG.6 (a), and Fig.7 (a) all have given the colored part 13 to one tubular member 2, but FIG.
  • Colored portions 13 may be applied to both tubular members 2. Further, when the colored portions 13 are respectively provided on the two tubular members 2, the color of one colored portion 13 is set to yellow, yellowish green, or green, and the color of the other colored portion 13 is set to the above-described color. The color may be the same color or a different color.
  • Example 1 A lacrimal tube having a laminated structure in which the end portion of the tubular member has a single layer and the main body has a four-layer structure was produced as follows. First, a base end tube made of polyurethane having the same diameter is brought into contact with the other end of a tube having a single layer and a main body having a four-layer structure. The rod side surfaces were connected and adjusted so that the position of the tip of the rod would be closer to one end side than the abutting surface, and the connection locations of each part were thermally welded at once. Next, a pair of tubular members and connections having the appearance shown in FIGS. 4 (a) to 4 (c) are formed by obliquely cutting the vicinity of one end side to the other end side of the base end portion to form an entrance / exit. A lacrimal tube having a member was prepared.
  • each member used is as follows.
  • Terminal part Low-density polyethylene terminal part length: approx. 4mm, diameter: 0.9-1.3mm taper taper
  • Main body Innermost layer (first layer): made of low-density polyethylene, inner intermediate layer (second layer): made of high-density polyethylene, outer intermediate layer (third layer): made of adhesive low-density polyethylene, outermost layer ( (Fourth layer): Made of polyurethane Lumen diameter: 0.96 mm Further, the distal end portion and the main body of the tubular member were in a transparent state so that they could be observed with a lacrimal endoscope from the lumen. (3) Base end made of polyurethane Inner diameter: 0.96 mm, Length: 5 mm (Connecting member) Diameter of polyurethane: 0.7mm Total length: 23mm
  • one end is placed on the end portion 8 on the same side as the connecting surface of the rod of the connecting member 3 (the side opposite to the position of the entrance / exit 11 of the base end portion 10).
  • a blue colored portion 12 formed to the end was provided.
  • the colored portion 12 was a series of lines, and was adjusted to a width of 1/10 of the total length around the end portion. Further, in one tubular member, the entire periphery of the main body 9 on the other end side from the colored portion 12 was colored yellow.
  • Example 1 Using the lacrimal tube obtained in Example 1, the lacrimal tube was placed in the actual lacrimal passage by the same insertion method as SEP. First, after inserting the probe of the lacrimal endoscope from the entrance and exit of the base end of the tube-shaped member colored yellow to the vicinity of the opening, it passes through the upper punctum canal from the upper punctum of the actual lacrimal passage. The lacrimal tube was inserted into the lower nasal passage. The inside of the lacrimal passage can be grasped by observing from the opening of the tubular member of the lacrimal tube, and when inserting, the direction of the colored portion of the tubular member can be confirmed without making a mistake in the direction. It was possible to insert it securely into the target place such as a closed part.
  • the lacrimal endoscope was removed and the lacrimal tube was placed in the lacrimal passage.
  • the probe of the lacrimal endoscope was easily grasped by finding the yellow colored portion.
  • the position of the lower nasal passage to be inserted could be easily grasped by confirming the direction of the yellow colored portion.
  • Test Example 2 In the two tubular members 2 in the lacrimal duct obtained in Example 1, on the same side as the position of the entrance / exit 11 of the proximal end 10 and the surface of the distal end 8 on the opposite side, FIG. As shown in (b), blue colored portions 12a and 12b were provided in a series of shapes each formed up to one end 4. In addition, as shown in FIG. 8, the width of the colored portion 12a on the same side as the entrance / exit 11 was adjusted to be narrower than the width of the colored portion 12b on the side opposite to the entrance / exit 11. The other configuration was the same as in Test Example 1.
  • the lacrimal duct tube was placed in the actual lacrimal passage by using the colored lacrimal duct tube by the same insertion method as SEP.
  • the end part was greatly deformed, but the presence of two colored parts in a diagonal relationship in the circumferential direction at the end makes the end part deformed and the opening Insertion was performed while accurately grasping the positional relationship between the head and lacrimal endoscope.
  • the width of the colored portion on the same side as the entrance / exit 11 of the two colored portions is narrowed, the direction of the lacrimal tube can be confirmed, and the direction of the lacrimal tube can be confirmed without mistake in the direction.
  • SYMBOLS 1 Lacrimal duct tube 2 Tubular member 3 Connection member 4 One end 5 Opening part 6 Lumen 7 Other end 8 Terminal part 9 Main body 10 Base end part 11 Entrance / exit 12 Colored part 13 Colored part on the other end side than the colored part 12 DESCRIPTION OF SYMBOLS 21 Upper punctum 22 Lower punctum 23 Upper lacrimal duct 24 Lower lacrimal duct 25 Total lacrimal duct 26 Lacrimal sac 27 Nasal lacrimal duct 28 Lower nasal passage 29 Lacrimal endoscope 30 Sheath 31 Lacrimal duct 32 Occlusion site 33 Lacrimal duct tube

Abstract

A tear duct tube comprising a pair of tube-shaped members with an opening at one end that communicates with the lumen and a connecting member for connecting the other ends of said tube-shaped members to each other. The tip comprising one end of at least one of the tube-shaped members is formed from a colorless material. On a portion of the circumference of the tip that is formed from the colorless material, a colored section is formed along the longitudinal direction of the tube-shaped member. The hue of the one tube-shaped member of the pair of tube-shaped members is a complementary hue or an adjacent complementary hue with respect to the hue of the colored section in the color wheel.

Description

涙道チューブLacrimal tube
 本発明は、涙道閉塞治療に用いる涙道チューブに関する。 The present invention relates to a lacrimal tube used for lacrimal passage obstruction treatment.
 流涙症をもたらす涙道閉塞の治療には、(i)涙道ブジーによるプロービング、(ii)涙道チューブの留置、(iii)涙嚢鼻腔吻合術(DCR)、(iv)涙小管形成術、(v)鼻涙管形成術、(vi)涙丘移動術などがある。 For treatment of lacrimal passage obstruction leading to lacrimation, (i) probing with lacrimal passage bougie, (ii) placement of lacrimal duct tube, (iii) lacrimal nasal sinus anastomosis (DCR), (iv) lacrimal tubuloplasty , (V) nasolacrimal duct arthroplasty, (vi) lacrimal cone movement.
 前記(i)の涙道ブジーによるプロービングは、ブジーと呼ばれる細管を涙道内に挿入することで閉塞部位を開通させ、涙液の流路を再建するものである。その後に使用する(ii)涙道チューブは、流路の維持と組織の再建を図るために留置する涙道内挿管器具である。これらの治療は容易で低侵襲であることから第一治療として行われる場合が多い。これに対して、(iii)涙嚢鼻腔吻合術(DCR)、(iv)涙小管形成術、(v)鼻涙管形成術、(vi)涙丘移動術は、効果は高いが、顔に切開を入れたり骨に穴をあけたりするので相対的に侵襲度が高く、最終手段として行われる。 The probing by the lacrimal passage bougie (i) described above is to open the occluded site by inserting a capillary tube called a bougie into the lacrimal passage and reconstruct the tear fluid flow path. The (ii) lacrimal tube used later is an intra lacrimal intubation device that is placed in order to maintain the flow path and reconstruct the tissue. Since these treatments are easy and minimally invasive, they are often performed as the first treatment. In contrast, (iii) lacrimal nasal sinus anastomosis (DCR), (iv) lacrimal tube formation, (v) nasolacrimal duct surgery, and (vi) lacrimal mobilization are highly effective, Since the incision is made and the hole is made in the bone, the degree of invasiveness is relatively high, and it is performed as a final means.
 前記(ii)において使用する涙道チューブは、前記(i)の涙道ブジーによるプロービングのあと、流路の維持と組織の再建を図るために留置するものである。前記(ii)の涙道チューブの留置は前述の(iii)~(vi)の各治療方法と比して容易で低侵襲、かつ効果が高い。その中でも特許文献1に示されるような、チューブの中央部分が細く柔らかいチューブやロッドで形成され、その両側が硬く太いチューブでできている涙道チューブ(例えば、特許文献1、2、3を参照)が広く普及している。 The lacrimal tube used in (ii) is placed in order to maintain the flow path and reconstruct the tissue after probing with the lacrimal bougie in (i). The placement of the lacrimal duct tube of (ii) is easier, less invasive and more effective than the treatment methods (iii) to (vi) described above. Among them, as shown in Patent Document 1, a lacrimal duct tube is formed of a thin and soft tube or rod at the center of the tube, and a hard and thick tube on both sides thereof (see, for example, Patent Documents 1, 2, and 3). ) Is widely spread.
 当該涙道チューブは、チューブと、該チューブの両側の切れ目から挿入された一対のブジーからなり、ブジーを操作してチューブを涙道内へと誘導し留置する。尚、図3に示すように、涙道は涙点(21、22)、涙小管(23、24)、涙嚢(26)、鼻涙管(27)などからなっている。この涙道内に涙道チューブが挿入される。 The lacrimal duct tube consists of a tube and a pair of bougies inserted from the cuts on both sides of the tube, and the bougie is operated to guide the tube into the lacrimal tract and place it. As shown in FIG. 3, the lacrimal passage is composed of the punctum (21, 22), lacrimal canal (23, 24), lacrimal sac (26), nasolacrimal duct (27), and the like. A lacrimal tube is inserted into the lacrimal passage.
 しかし、前記涙道チューブを挿入するためには、ブジーを用いた涙道内での操作を術者の指先の感覚を頼りとした手探り状態で行わなければならず、術者に高度な操作技術がないとブジーがチューブを突き破ったり、また正常な涙道以外に穴を開ける(仮道)こともあり、その場合、治療成績は不良であった。 However, in order to insert the lacrimal tube, the operation inside the lacrimal passage using a bougie must be performed in a groping state that relies on the sense of the operator's fingertips, and the operator has advanced operation technology. Otherwise, the bougie may break through the tube or make a hole other than the normal lacrimal tract (temporary tract), in which case the treatment results were poor.
 そこで、近年の涙道閉塞治療の分野では、より安全で確実な治療を行う観点から、涙道チューブ挿入術として、シース誘導内視鏡下穿破法(SEP)とシース誘導チューブ挿入法(SGI)とを組み合わせた挿入術が行われている。 Therefore, in the field of lacrimal passage obstruction treatment in recent years, from the viewpoint of performing safer and more reliable treatment, as the lacrimal tube insertion, sheath-guided endoscopic puncture (SEP) and sheath-guided tube insertion (SGI) ) Is combined with the insertion technique.
 SEPでは、涙道内視鏡に被せたテフロン(登録商標)製またはポリウレタン製の外筒部分のシースを涙道内視鏡よりも先行させて涙点に挿入し、涙道内視鏡で涙道内を観察しながら閉塞部を穿破し、次いで、シース先端が鼻涙管開口部から出る位置まで挿入を行った後、シースを残したままで涙道内視鏡のみ抜去する。例えば、図1(a)、(b)に示すように涙道内視鏡29に装着したシース30を、上涙点21から上涙小管23を経て涙道31の下鼻道28にある閉塞部位32に挿入し、この閉塞部位32を貫通した後、涙道内視鏡29を取り外す。 In SEP, a Teflon (registered trademark) or polyurethane outer sheath covering the lacrimal endoscope is inserted into the punctum before the lacrimal endoscope, and the inside of the lacrimal passage is observed with the lacrimal endoscope The occlusion portion is punctured, and then the insertion is performed until the sheath tip comes out from the opening of the nasolacrimal duct, and then only the lacrimal endoscope is removed while leaving the sheath. For example, as shown in FIGS. 1A and 1B, a sheath 30 attached to the lacrimal endoscope 29 is blocked by the lower nasal passage 28 of the lacrimal passage 31 from the upper punctum 21 through the upper lacrimal tubule 23. After inserting into the occlusion site 32 and penetrating through the occlusion site 32, the lacrimal endoscope 29 is removed.
 SGIでは、前記SEPにて挿入した涙点側のシース端部に涙道チューブを連結し、鼻内視鏡観察下で閉塞部から出たシース先端を鉗子でつまんで引き出す。このことにより涙道チューブはシースに引かれてSEPにて開放された閉塞部のスペースに挿入される。その後シースと涙道チューブの連結を外し留置が完了する。例えば、図2(a)に示すように前記シース30に涙道チューブ33を接続し、図2(b)に示すように前記涙道チューブ33を接続した側と反対の側から前記シース30を引っ張って涙道31内に前記涙道チューブ33を挿入して閉塞部位32を貫通させる。次に、図2(c)に示すように前記シース30を取り外して前記涙道チューブ33を涙道31内に留置する。 In SGI, the lacrimal tube is connected to the end of the punctum-side sheath inserted in the SEP, and the sheath tip that has come out of the occluded portion is pinched with forceps under nasal endoscopy. As a result, the lacrimal duct tube is pulled by the sheath and inserted into the space of the closed portion opened by SEP. Thereafter, the connection between the sheath and the lacrimal duct tube is removed, and the placement is completed. For example, the lacrimal tube 33 is connected to the sheath 30 as shown in FIG. 2 (a), and the sheath 30 is connected to the side opposite to the side where the lacrimal tube 33 is connected as shown in FIG. 2 (b). By pulling, the lacrimal duct tube 33 is inserted into the lacrimal passage 31 to penetrate the occlusion site 32. Next, as shown in FIG. 2C, the sheath 30 is removed and the lacrimal tube 33 is placed in the lacrimal passage 31.
 次いで、図示しないが、涙道内視鏡29に装着した別のシース30を、涙道チューブ33を挿入していない下涙点22から下涙小管24を経て涙道31の下鼻道28にある閉塞部位32に挿入し、この閉塞部位32を貫通した後、涙道内視鏡29を取り外し、このシース30に、前記閉塞部位32を貫通していない涙道チューブ33の端部を接続し、前記涙道チューブ33を接続した側と反対の側から前記シース30を引っ張って涙道チューブ33のもう一方の端部を貫通させ、最後に前記シース30を取り外して、図3に示すように前記涙道チューブ33を涙道31内に留置する。 Next, although not shown, another sheath 30 attached to the lacrimal endoscope 29 is located in the lower nasal passage 28 of the lacrimal passage 31 from the lower lacrimal point 22 where the lacrimal passage tube 33 is not inserted, through the lower lacrimal tubule 24. After inserting into the occlusion site 32 and penetrating through the occlusion site 32, the lacrimal endoscope 29 is removed, and the end of the lacrimal tube 33 that does not penetrate the occlusion site 32 is connected to the sheath 30, The sheath 30 is pulled from the side opposite to the side where the lacrimal tube 33 is connected to penetrate the other end of the lacrimal tube 33, and finally the sheath 30 is removed, as shown in FIG. The canal tube 33 is placed in the lacrimal passage 31.
 前記のSEPとSGIとを組み合わせた挿入術は、従来のように盲目的に行うのではなく、閉塞部の穿破を涙道内視鏡下で実施できる点で安全性に優れた方法である。また、SEPに用いるシースは剛性の高い材質でできているため、手元部からの操作、力が先端にダイレクトに伝わり微細な操作を行うことができ、また、術中に涙道内視鏡が折れたり、先端部ファイバーが破損したりするリスクも少ないという利点がある。
 しかしながら、前記の従来のシースを用いた手技においては、入り組んだ形状で暗く、かつ閉塞している涙道内にシースを挿入していくのは涙道内視鏡を用いても難しく、粘膜にシース等が突き刺さり仮道を形成したり、もともとあった仮道に誤って挿入したりする可能性があった。
The insertion method combining the SEP and SGI is not a blind method as in the prior art, but is an excellent safety method in that the puncture of the occlusion can be performed under a lacrimal endoscope. In addition, since the sheath used for SEP is made of a highly rigid material, the manipulation from the hand and the force can be transmitted directly to the tip for fine manipulation, and the lacrimal endoscope can be broken during the operation. There is an advantage that there is little risk that the tip fiber is broken.
However, in the procedure using the conventional sheath described above, it is difficult to insert a sheath into a lacrimal passage that is dark and obstructed with an intricate shape, even if a lacrimal endoscope is used. However, there was a possibility that it would pierce and form a temporary road, or insert it into the original temporary road by mistake.
特許第2539325号公報Japanese Patent No. 2539325 特許第3558924号公報Japanese Patent No. 3558924 特開2004-202276号公報JP 2004-202276 A
 上記のような事情に鑑み、本発明の目的は、SEPと同様の涙道閉塞治療に好適に使用できる涙道チューブ、具体的には、涙道内視鏡に装着して手技を行う際に、容易に自身の先端位置や涙道閉塞部を確認でき、さらに、後から挿入時には先に挿入・留置された涙道チューブの一部を道標にして、簡便かつ安全に、涙道閉塞治療を行える涙道チューブを提供することにある。 In view of the circumstances as described above, the object of the present invention is to provide a lacrimal tube that can be suitably used for the treatment of lacrimal passage obstruction similar to SEP, specifically, when performing a procedure by attaching to a lacrimal endoscope. Easily confirm your own tip position and lacrimal tract occlusion, and easily and safely treat lacrimal tract occlusion by using a portion of the lacrimal tube inserted and indwelled at the time of insertion later. To provide a lacrimal tube.
 本発明者らは、かかる課題を解決すべく、鋭意検討を進めた。その結果、涙道チューブを構成するチューブ状部材の一方端にある末端部に着目し、末端部に着色部を設けることで、暗い涙道内で操作しても所望の位置に確実に涙道チューブを挿入することができることを見出し、本発明を完成するに至った。 The present inventors have intensively studied to solve such problems. As a result, paying attention to the end portion at one end of the tube-shaped member constituting the lacrimal tube, and providing a colored portion at the end portion, the lacrimal tube is surely placed at a desired position even when operated in the dark lacrimal passage Has been found to be able to be inserted, and the present invention has been completed.
 即ち、本発明の要旨は以下の通りである。 That is, the gist of the present invention is as follows.
 〔1〕一方端に内腔へ連通する開口部を有する一対のチューブ状部材と、これらチューブ状部材の他方端同士をつなぐ接続部材と、を含む涙道チューブであって、
 少なくとも一方の前記チューブ状部材における一方端を含む末端部が無色材料で形成され、
 前記無色材料で形成される前記末端部の周囲の一部に、前記チューブ状部材の長軸方向に沿う着色部が形成され、
 一対の前記チューブ状部材の一方のチューブ状部材の色相が、色相環にて、前記着色部の色相に対して補色色相または隣接補色色相であること
を特徴とする涙道チューブ。
[1] A lacrimal duct tube comprising a pair of tubular members having an opening communicating with the lumen at one end, and a connecting member connecting the other ends of the tubular members,
A terminal portion including one end of at least one of the tubular members is formed of a colorless material,
A colored portion along the longitudinal direction of the tubular member is formed on a part of the periphery of the end portion formed of the colorless material,
A lacrimal duct tube, wherein a hue of one tube-shaped member of the pair of tube-shaped members is a complementary color hue or an adjacent complementary color hue with respect to the hue of the colored portion in a hue ring.
 〔2〕前記着色部が前記一方端にまで形成されている前記〔1〕に記載の涙道チューブ。 [2] The lacrimal duct tube according to [1], wherein the colored portion is formed up to the one end.
 〔3〕前記着色部が一連状の線または破線である前記〔1〕または〔2〕に記載の涙道チューブ。 [3] The lacrimal duct tube according to [1] or [2], wherein the colored portion is a series of lines or broken lines.
 〔4〕前記着色部が前記末端部の周囲全長に対する1/50以上1/3以下の長さの幅を有する前記〔1〕~〔3〕のいずれかに記載の涙道チューブ。 [4] The lacrimal duct tube according to any one of [1] to [3], wherein the colored portion has a width of 1/50 or more and 1/3 or less with respect to the entire peripheral length of the end portion.
 〔5〕前記チューブ状部材における前記着色部が、前記チューブ状部材の周囲方向における、チューブ状部材の他方端側にある出入口の位置と同じ側および反対側の少なくとも一方側に形成されている前記〔1〕~〔4〕のいずれかに記載の涙道チューブ。 [5] The colored portion in the tubular member is formed on the same side as the position of the entrance / exit on the other end side of the tubular member in the circumferential direction of the tubular member and at least one side opposite to the position. The lacrimal duct tube according to any one of [1] to [4].
 〔6〕前記着色部が前記チューブ状部材の周囲方向における出入口の位置と同じ側および反対側に形成されており、一方の着色部の幅が他方の着色部の幅と異なるように形成されている前記〔5〕に記載の涙道チューブ。 [6] The colored portion is formed on the same side as the position of the entrance / exit in the circumferential direction of the tubular member and on the opposite side, and the width of one colored portion is different from the width of the other colored portion. The lacrimal duct tube according to [5] above.
 〔7〕幅の細い前記着色部が、前記チューブ状部材の周囲方向における出入口の位置と同じ側に形成され、幅の太い前記着色部が、反対側に形成されている前記〔6〕に記載の涙道チューブ。 [7] The colored portion having a narrow width is formed on the same side as the position of the entrance / exit in the circumferential direction of the tubular member, and the colored portion having a large width is formed on the opposite side. Lacrimal duct tube.
 〔8〕着色された前記チューブ状部材の色が黄色であり、前記着色部の色が青色である前記〔1〕~〔7〕のいずれかに記載の涙道チューブ。 [8] The lacrimal duct tube according to any one of [1] to [7], wherein the colored tubular member is yellow and the colored portion is blue.
 本発明の涙道チューブによれば、少なくとも一方の前記チューブ状部材における一方端を含む末端部が無色材料で形成されることで、手技中において涙道チューブに挿入にしている涙道内視鏡からの視野を確保することができる。
 また、前記無色材料で形成される末端部の周囲の一部にチューブ状部材の長軸方向に沿う着色部が形成されることで、手技中において涙道内視鏡の観察下で、末端部の位置を容易に確認することができる。
 また、本発明の涙道チューブのチューブ状部材の色相が色相環にて前記着色部の色相に対して補色色相または隣接補色色相であることで、涙道中の暗い環境下に挿入されているチューブ状部材の具体的な位置を容易に確認することができる。
According to the lacrimal duct tube of the present invention, the distal end portion including one end of at least one of the tubular members is formed of a colorless material, so that the lacrimal duct endoscope is inserted into the lacrimal duct tube during the procedure. Can be ensured.
Further, by forming a colored portion along the longitudinal direction of the tubular member in a part of the periphery of the distal portion formed of the colorless material, the distal portion of the distal portion can be observed under the observation of the lacrimal endoscope during the procedure. The position can be easily confirmed.
Further, the tube inserted in the dark environment in the lacrimal passage is that the hue of the tube-shaped member of the lacrimal passage tube of the present invention is a complementary hue or an adjacent complementary hue with respect to the hue of the colored portion in the hue ring The specific position of the member can be easily confirmed.
SEPに基づく涙道閉塞部の手術の一例を示す概略説明図である。It is a schematic explanatory drawing which shows an example of the surgery of the lacrimal passage obstruction | occlusion part based on SEP. SGIに基づく涙道閉塞部の手術の一例を示す概略説明図である。It is a schematic explanatory drawing which shows an example of the surgery of the lacrimal passage obstruction | occlusion part based on SGI. 涙道の解剖学的な構造および涙道閉塞具が留置された状態を示す説明図である。It is explanatory drawing which shows the state in which the anatomical structure of the lacrimal passage and the lacrimal passage obturator were detained. 本発明の涙道チューブの一例を示す概略図である。It is the schematic which shows an example of the lacrimal duct tube of this invention. 本発明の涙道チューブの一例を示す概略図である。It is the schematic which shows an example of the lacrimal duct tube of this invention. 本発明の涙道チューブの一例を示す概略図である。It is the schematic which shows an example of the lacrimal duct tube of this invention. 本発明の涙道チューブの一例を示す概略図である。It is the schematic which shows an example of the lacrimal duct tube of this invention. 本発明の涙道チューブの末端部に形成した着色部の一例を示す概略図である。It is the schematic which shows an example of the coloring part formed in the terminal part of the lacrimal duct tube of this invention. 本発明の涙道チューブの一例を示す概略図である。It is the schematic which shows an example of the lacrimal duct tube of this invention.
 以下、本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail.
 本発明でいう涙道とは、図3に示すように、上/下涙点(21/22)、上/下涙小管(23/24)、総涙小管(25)、涙嚢(26)、鼻涙管(27)、鼻腔管(図示せず)、Hasner’s valve(図示せず)から構成され、涙腺(図示せず)から産出された涙液を眼表面から下鼻道(28)へと導く管(眼球付属器)である。図3は、涙道の解剖学的な構造を模式的に示したものである。尚、上涙点(21)から、上涙小管(23)、総涙小管(25)を経て下鼻道(28)へと導く管を上涙道といい、下涙点(22)から下涙小管(24)、総涙小管(25)を経て下鼻道(28)へと導く管を下涙道という。 As shown in FIG. 3, the lacrimal passage referred to in the present invention is the upper / lower punctum (21/22), upper / lower lacrimal duct (23/24), total lacrimal duct (25), lacrimal sac (26) , Lacrimal duct (27), nasal duct (not shown), Hasner's valve (not shown), and tears produced from the lacrimal gland (not shown) are transferred from the ocular surface to the lower nasal passage (28 ) Is a tube (eyeball appendage) that leads to FIG. 3 schematically shows the anatomical structure of the lacrimal passage. The tube leading from the upper punctum (21) to the lower nasal passage (28) through the upper lacrimal canal (23) and the total lacrimal canal (25) is called the upper lacrimal passage. The duct leading to the lower nasal passage (28) through the lacrimal canal (24) and the total lacrimal duct (25) is called the lower lacrimal passage.
 本発明の涙道チューブは、一方端に内腔へ連通する開口部を有する一対のチューブ状部材と、これらチューブ状部材の他方端同士をつなぐ接続部材と、を含む涙道チューブであって、
 少なくとも一方の前記チューブ状部材における一方端を含む末端部が無色材料で形成され、
 前記無色材料で形成される前記末端部の周囲の一部に、前記チューブ状部材の長軸方向に沿う着色部が形成され、
 一対の前記チューブ状部材の一方のチューブ状部材の色相が、色相環にて、前記着色部の色相に対して補色色相または隣接補色色相であること
を特徴とする。
The lacrimal tube of the present invention is a lacrimal tube including a pair of tubular members having an opening communicating with the lumen at one end, and a connecting member connecting the other ends of the tubular members,
A terminal portion including one end of at least one of the tubular members is formed of a colorless material,
A colored portion along the longitudinal direction of the tubular member is formed on a part of the periphery of the end portion formed of the colorless material,
The hue of one tubular member of the pair of tubular members is a complementary color hue or an adjacent complementary hue with respect to the hue of the colored portion in a hue ring.
 前記チューブ状部材の構造としては、同一の樹脂組成物からなる一体型のチューブでもよいし、樹脂の種類が異なる複数の層が厚み方向に積層された積層構造、樹脂の種類が異なる複数のチューブが長軸方向に連結された列構造を有するチューブでもよい。 The structure of the tubular member may be an integrated tube made of the same resin composition, a laminated structure in which a plurality of layers of different types of resin are laminated in the thickness direction, or a plurality of tubes of different types of resin May be a tube having a row structure in which are connected in the longitudinal direction.
 前記チューブ状部材を構成する樹脂としては、特に限定はなく、例えば、ポリエチレン、シリコーン、ポリアミドエラストマー、ポリウレタン、イソブチレン系共重合体、およびこれらのアロイなどを含む樹脂組成物が挙げられるが、これらに限定されない。
 本発明では、上記アロイとしては特に限定はないが、例えば、ポリウレタンとイソブチレン系共重合体のアロイを用いる場合、前記イソブチレン系ブロック共重合体(A)と、熱可塑性ポリウレタン系樹脂(B)との割合を調整することで、チューブの硬さを調整できる。熱可塑性ポリウレタン系樹脂(B)の割合を大きく設定するほど、チューブの硬度を大きくすることができる。尚、抗血栓性、表面滑り性、柔軟性の観点から考えると、イソブチレン系ブロック共重合体(A)が1重量%以上含まれていることが好ましい(即ち、イソブチレン系ブロック共重合体(A)と熱可塑性ポリウレタン系樹脂(B)の割合が、重量比で(A)/(B)=1/99~99/1)。中でも、耐摩耗性の観点から考えると、イソブチレン系ブロック共重合体(A)と熱可塑性ポリウレタン系樹脂(B)の割合が、重量比で(A)/(B)=1/99~70/30であることが好ましい。特に、圧縮応力の観点から考えると、イソブチレン系ブロック共重合体(A)と熱可塑性ポリウレタン系樹脂(B)の割合が、重量比で(A)/(B)=1/99~50/50であることが好ましい。本発明に用いられる一体のチューブ用の樹脂組成物はイソブチレン系ブロック共重合体(A)と熱可塑性ポリウレタン系樹脂(B)のみからなるものでもよいが他の成分を混合してもよい。
The resin constituting the tubular member is not particularly limited, and examples thereof include polyethylene, silicone, polyamide elastomer, polyurethane, isobutylene copolymers, and resin compositions containing these alloys. It is not limited.
In the present invention, the alloy is not particularly limited. For example, when an alloy of polyurethane and an isobutylene copolymer is used, the isobutylene block copolymer (A), the thermoplastic polyurethane resin (B), and The hardness of the tube can be adjusted by adjusting the ratio. The greater the ratio of the thermoplastic polyurethane resin (B), the greater the hardness of the tube. In view of antithrombogenicity, surface slipperiness, and flexibility, the isobutylene block copolymer (A) is preferably contained in an amount of 1% by weight or more (that is, the isobutylene block copolymer (A ) And the thermoplastic polyurethane resin (B) are in a weight ratio (A) / (B) = 1/99 to 99/1). Among these, from the viewpoint of wear resistance, the ratio of the isobutylene block copolymer (A) and the thermoplastic polyurethane resin (B) is (A) / (B) = 1/99 to 70 / weight ratio. 30 is preferable. In particular, from the viewpoint of compressive stress, the ratio of the isobutylene block copolymer (A) to the thermoplastic polyurethane resin (B) is (A) / (B) = 1/99 to 50/50 in weight ratio. It is preferable that The resin composition for an integral tube used in the present invention may be composed of only the isobutylene block copolymer (A) and the thermoplastic polyurethane resin (B), but may be mixed with other components.
 イソブチレン系ブロック共重合体(A)として、スチレン-イソブチレン-スチレンブロック共重合体(以下、SIBSという場合がある)であるカネカ社製の「SIBSTAR102T」が好ましい。熱可塑性ポリウレタン系樹脂(B)(以下、TPUという場合がある)として、エーテル系芳香環式ポリウレタンである日本ミラクトラン社製の「ミラクトランE385PNAT」、Lubrizol社製「テコタンTT1074A」またはエーテル系脂環式ポリウレタンであるLubrizol社製の「テコフレックスEG100A」、「テコフレックスEG85A」またはポリカーボネート系ポリウレタンであるLubrizol社製「カルボタンPC3575A」などが好ましい。 As the isobutylene block copolymer (A), “SIBSTAR102T” manufactured by Kaneka Corporation, which is a styrene-isobutylene-styrene block copolymer (hereinafter sometimes referred to as SIBS), is preferable. As the thermoplastic polyurethane resin (B) (hereinafter sometimes referred to as TPU), “Milactolan E385PNAT” manufactured by Nippon Milactolan, which is an ether type aromatic cyclic polyurethane, “Tecotan TT1074A” manufactured by Lubrizol, or ether type alicyclic type “Tecoflex EG100A” and “Tecoflex EG85A” manufactured by Lubrizol, which are polyurethanes, and “Calbutton PC3575A” manufactured by Lubrizol, which is a polycarbonate-based polyurethane, are preferable.
 前記チューブ状部材が、厚み方向の積層構造を有するチューブである場合、各層に使用する樹脂を変えてもよい。例えば、内側の層には、挿入術を行う際、涙道チューブのプッシャビリティを向上させるために、剛性の高い樹脂としてポリエチレンを使用することが好ましい。また、外側の層には、涙道内と接触する部分にはより柔らかい材質の樹脂としてポリウレタンを使用することが好ましい。
 前記積層構造が3層である場合には、最外層にポリウレタンを使用し、中間層に接着性のあるポリエチレンを使用し、最内層に剛性の高いポリエチレンを使用することで、閉塞部穿破のためのプッシャビリティを得ることができ、かつ涙道内で操作した場合の安全性に優れるという利点がある。
 4層以上の場合でも、最外層にはポリウレタン、最内層には剛性の高いポリエチレンを使用することが好ましい。
 また、各層同士は、チューブ状部材の長軸方向全体にわたって溶着することで剛性の連続性が保たれ、キンクが生じにくく、涙道チューブを挿入時に力が他方端側から一方端側へ伝わり易く、操作性に優れるという利点がある。
When the tube-shaped member is a tube having a laminated structure in the thickness direction, the resin used for each layer may be changed. For example, for the inner layer, it is preferable to use polyethylene as a highly rigid resin in order to improve the pushability of the lacrimal duct tube during insertion. In addition, it is preferable to use polyurethane as a softer resin for the outer layer in the portion that contacts the lacrimal passage.
When the laminated structure has three layers, polyurethane is used for the outermost layer, adhesive polyethylene is used for the intermediate layer, and high-rigidity polyethylene is used for the innermost layer. Therefore, there is an advantage that the pushability can be obtained and the safety when operated in the lacrimal passage is excellent.
Even in the case of four or more layers, it is preferable to use polyurethane for the outermost layer and highly rigid polyethylene for the innermost layer.
Also, each layer is welded over the entire long axis direction of the tube-shaped member, so that the continuity of rigidity is maintained, kink hardly occurs, and the force is easily transmitted from the other end side to the one end side when inserting the lacrimal tube. There is an advantage that it is excellent in operability.
 前記チューブ状部材の内腔は、涙道チューブを涙道に挿入する際にはチューブ状部材の基端部に設けた出入口から挿入した涙道内視鏡を収容するための空間となり、また涙道チューブを涙道内に留置した際にはチューブ状部材の基端部に設けた出入口を通じて涙などの体液の流路となる。 When the lacrimal tube is inserted into the lacrimal passage, the lumen of the tubular member serves as a space for accommodating the lacrimal endoscope inserted from the entrance provided at the proximal end of the tubular member, and the lacrimal passage When the tube is placed in the lacrimal passage, it becomes a flow path for bodily fluids such as tears through an entrance provided at the proximal end of the tubular member.
 前記チューブ状部材の一方端にある開口部は、涙道チューブを留置した際には涙などの体液の流路の一部となり、また基端部に設けた出入口から挿入した涙道内視鏡の先端部を前記開口部付近にまで挿入した際には、前記開口部を経て涙道内視鏡からの視野を確保して、チューブが仮道を作ったりして、粘膜等を傷付け出血を引き起こす等の問題を避けることができる。 The opening at one end of the tubular member becomes a part of a flow path for bodily fluids such as tears when the lacrimal tube is indwelled, and of the lacrimal endoscope inserted from the entrance / exit provided at the base end. When the tip is inserted to the vicinity of the opening, the visual field from the lacrimal endoscope is secured through the opening, the tube forms a temporary path, and the mucous membrane is damaged, causing bleeding, etc. Can avoid problems.
 また、前記チューブ状部材の外径は、涙道に挿入可能な範囲であればよいが、例えば、最大外径は0.8mm以上1.7mm以下であれば、国籍、性別の違いによらず、幅広い患者の涙道に対応することができる。 The outer diameter of the tube-shaped member may be in a range that can be inserted into the lacrimal passage. For example, if the maximum outer diameter is 0.8 mm or more and 1.7 mm or less, regardless of the difference in nationality and gender. Can handle a wide range of patient lacrimal passages.
 前記チューブ状部材の長さとしては、市販の涙道チューブと同じ程度であればよく、特に限定はない。 The length of the tubular member is not particularly limited as long as it is about the same as a commercially available lacrimal duct tube.
 前記チューブ状部材には、接続部材と接続している他方端側にチューブ状部材の内腔に通じる出入口を有している。出入口は、涙道内視鏡などの涙道操作具を挿入・排出するための出入口となるだけでなく、涙道チューブが涙道内に留置された場合には涙などの体液の出入口になる。
 前記出入口は、チューブ状部材の壁に形成されていてもよいし、チューブ状部材の基端部に、例えば、接続部材に向かってチューブ状の基端部を斜めカットすることで形成されていてもよい。
 前記出入口の形状や面積について、特に限定はない。
The tubular member has an inlet / outlet communicating with the lumen of the tubular member on the other end side connected to the connecting member. The entrance / exit is not only an entrance / exit for inserting / extracting a lacrimal passage manipulator such as a lacrimal endoscope, but also an entrance / exit of a body fluid such as a tear when the lacrimal tube is placed in the lacrimal passage.
The entrance / exit may be formed on the wall of the tubular member, or may be formed on the proximal end of the tubular member by, for example, obliquely cutting the tubular proximal end toward the connecting member. Also good.
There is no particular limitation on the shape and area of the entrance / exit.
 本発明の涙道チューブでは、少なくとも一方の前記チューブ状部材における一方端を含む末端部が無色材料で形成されている点に一つの特徴があり、この特徴を有することで、涙道内視鏡を涙道チューブに挿入した状態で、チューブ状部材の開口部からだけでなく、チューブ状部材の壁面からも外部の様子を涙道内視鏡で観察することが可能になる。 The lacrimal duct tube of the present invention has one feature in that a terminal portion including one end of at least one of the tubular members is formed of a colorless material. By having this feature, the lacrimal endoscope is provided. In a state of being inserted into the lacrimal duct tube, not only from the opening of the tubular member but also from the wall surface of the tubular member, it is possible to observe the external state with a lacrimal endoscope.
 前記末端部を構成する末端部を構成する無色材料には、全く色がついていない透明な材料のほか、構成樹脂に由来する着色があっても、内腔にある涙道内視鏡から壁部を通して外部の様子が観察できる程度に透明な材料(例えば、半透明な青色)も含まれる。 The colorless material constituting the end portion includes a transparent material having no color at all, and even if there is a color derived from the constituent resin, it passes through the wall from the lacrimal duct endoscope in the lumen. A material transparent to such an extent that an external state can be observed (for example, translucent blue) is also included.
 前記末端部の全長の範囲については特に限定はなく、一方端から2~10mmの範囲であればよい。 The total length of the end portion is not particularly limited, and may be in the range of 2 to 10 mm from one end.
 本発明の涙道チューブでは、少なくとも一方のチューブ状部材において前記無色材料で形成される前記末端部の周囲の一部に、前記チューブ状部材の長軸方向に沿う着色部が単数または複数形成されている点にも一つの特徴があり、この特徴を有することで、チューブ状部材の開口部からだけでなく、チューブ状部材の壁面からも外部の様子を涙道内視鏡で観察できることに加えて、手技中に末端部の位置を確認することが可能になる。
 前記着色部は、さらにチューブ状部材の一方端まで形成されていると、手技中に涙道内にあるチューブ状部材の一方端の位置まで確認することができる。
In the lacrimal duct tube of the present invention, at least one tubular member is formed with one or more colored portions along the major axis direction of the tubular member around a part of the end portion formed of the colorless material. In addition to being able to observe the external appearance not only from the opening of the tube-like member but also from the wall surface of the tube-like member with a lacrimal endoscope, this feature also has a feature. It becomes possible to confirm the position of the end portion during the procedure.
When the colored portion is further formed to one end of the tubular member, it can be confirmed to the position of one end of the tubular member in the lacrimal passage during the procedure.
 前記着色部の形状については、特に限定はないが、一連状の線または破線であることで、チューブ状部材の末端部の位置や状態を、そのチューブ状部材の内腔にある涙道内視鏡から観察して把握することが容易になり正確な涙道チューブ挿入術が行えるという利点がある。 The shape of the colored portion is not particularly limited, but it is a series of lines or broken lines, so that the position and state of the distal end portion of the tubular member can be determined by the lacrimal endoscope located in the lumen of the tubular member. Therefore, there is an advantage that it is easy to observe and grasp from, and accurate lacrimal tube insertion can be performed.
 前記着色部が前記末端部の周囲全長に対する1/50以上1/3以下の長さの幅を有することで、手技中に涙道内に挿入されているチューブ状部材の末端部の位置や状態を、そのチューブ状部材の内腔にある涙道内視鏡から観察して把握することがより容易になる。前記着色部の幅は、1/20以上1/5以下がより好ましい。 Since the colored portion has a width of 1/50 or more and 1/3 or less of the total peripheral length of the end portion, the position and state of the end portion of the tubular member inserted into the lacrimal passage during the procedure It becomes easier to observe and grasp from the lacrimal endoscope in the lumen of the tubular member. The width of the colored part is more preferably 1/20 or more and 1/5 or less.
 また、前記チューブ状部材における前記着色部の位置は、特に限定はないが、例えば、前記チューブ状部材の他方端側に設けた出入口の位置を基準として、周囲方向における出入口の位置と同じ側および反対側の少なくとも一方側に形成されていると、涙道内視鏡から観察できる着色部の位置と、基端部の出入口の位置から、末端部の向きも確認することができる。
 中でも、チューブ状部材の周囲方向における出入口の位置と同じ側および反対側に着色部を形成している場合、涙道内の閉塞部を穿破する際に末端部が変形しても、末端部の変形状態、かつ、開口部と涙道内視鏡との位置関係を正確に把握することができる。
 さらに、前記複数の着色部の幅を変えること、例えば、幅の細い前記着色部(幅細着色部)が、前記チューブ状部材の周囲方向における出入口の位置と同じ側に形成され、幅の太い前記着色部(幅広着色部)が、反対側に形成されていることで、涙道チューブの向きを確認することができ、方向を間違えずに目的の場所に確実に涙道チューブを挿入することがより簡単になる。もちろん、幅広着色部が、前記チューブ状部材の周囲方向における出入口の位置と同じ側に形成され、幅細着色部が、反対側に形成されていても、上記同様の効果を奏する。ただし、幅広着色部が前記チューブ状部材の周囲方向における出入口の位置に対して反対側に形成されている方が、出入口、ひいては涙道チューブの向きを比較的容易に把握でき、正確な挿入術を使いやすい。
Further, the position of the colored portion in the tubular member is not particularly limited, and for example, the same side as the position of the entrance and exit in the circumferential direction with reference to the position of the entrance and exit provided on the other end side of the tubular member and If formed on at least one side of the opposite side, the direction of the distal end can also be confirmed from the position of the colored portion that can be observed from the lacrimal endoscope and the position of the entrance / exit of the proximal end.
In particular, when the colored part is formed on the same side as the position of the entrance / exit in the circumferential direction of the tubular member and on the opposite side, even if the terminal part is deformed when the closed part in the lacrimal passage is pierced, the terminal part It is possible to accurately grasp the deformed state and the positional relationship between the opening and the lacrimal endoscope.
Furthermore, changing the width of the plurality of colored portions, for example, the narrow colored portion (thin colored portion) is formed on the same side as the position of the entrance / exit in the circumferential direction of the tubular member, and has a large width. Since the colored portion (wide colored portion) is formed on the opposite side, the direction of the lacrimal tube can be confirmed, and the lacrimal tube is surely inserted into the target place without making a mistake in the direction. Becomes easier. Of course, even when the wide colored portion is formed on the same side as the position of the entrance / exit in the circumferential direction of the tubular member and the narrow colored portion is formed on the opposite side, the same effect as described above is obtained. However, when the wide colored portion is formed on the opposite side to the position of the entrance / exit in the circumferential direction of the tubular member, the orientation of the entrance / exit, and hence the lacrimal duct tube, can be grasped relatively easily, and accurate insertion Easy to use.
 前記着色部の具体的な色については、特に限定はないが、鼻腔内はおおむね赤色であるため、涙道内視鏡を通して目で確認し易いように、色相環にて赤色と補色色相または隣接補色色相の関係になる色に調整すればよく、例えば、青、シアン等が挙げられる。 There is no particular limitation on the specific color of the colored portion, but since the inside of the nasal cavity is generally red, red and complementary colors or adjacent complementary colors are used in the hue circle so that the eyes can be easily confirmed through the lacrimal endoscope. What is necessary is just to adjust to the color used as a hue relationship, for example, blue, cyan, etc. are mentioned.
 また、前記着色部は少なくとも1本のチューブ状部材の末端部に設けていればよいし、2本のチューブ状部材の末端部に着色部がそれぞれ設けられていてもよい。2本のチューブ状部材に着色部が設けられている場合、それぞれの着色部の色は同じでも異なっていてもよい。また、一連状の線または破線の着色部が設けられており、前記線が複数ある場合には、各線の色は同じでも異なっていてもよい。 Further, the colored portion may be provided at the end portion of at least one tubular member, or the colored portion may be provided at the end portions of the two tubular members. When the colored part is provided in two tube-shaped members, the color of each colored part may be the same or different. In addition, a series of line or broken line colored portions are provided, and when there are a plurality of the lines, the colors of the lines may be the same or different.
 本発明の涙道チューブでは、一対の前記チューブ状部材の一方のチューブ状部材の色相が、色相環にて、前記着色部の色相に対して補色色相または隣接補色色相であることで、涙道中の暗い環境下に挿入されているチューブ状部材の具体的な位置を容易に確認することができる。 In the lacrimal duct tube of the present invention, the hue of one tube-shaped member of the pair of tube-shaped members is a complementary color hue or an adjacent complementary color hue with respect to the hue of the colored portion in the hue ring, The specific position of the tubular member inserted in the dark environment can be easily confirmed.
 具体的には、前記着色部を有するチューブ状部材では、着色部から他方端側のチューブ状部材の全周囲にも着色を行っていればよい。
 従来のシースを用いた手技においては、入り組んだ形状で暗く、かつ閉塞している涙道内にシースを挿入していくのは涙道内視鏡を用いても難しく、粘膜にシース等が突き刺さり仮道を形成したり、もともとあった仮道に誤って挿入したりする可能性があった。
 しかし、前記のように、着色部から他方端側のチューブ状部材の全周囲に着色を行っていれば、先に涙道内に挿入されているチューブ状部材の位置を、後から挿入するチューブ状部材内の涙道内視鏡から確認し、それを道標にして、正確な挿入術を行える。そのため、仮道の形成などを防止できる。
Specifically, in the tubular member having the colored portion, the entire periphery of the tubular member on the other end side from the colored portion may be colored.
In a procedure using a conventional sheath, it is difficult to insert a sheath into a lacrimal passage that is dark and obstructed with an intricate shape, even if a lacrimal endoscope is used. Could be formed or accidentally inserted into the original temporary road.
However, as described above, if the entire periphery of the tube-shaped member on the other end side is colored from the colored portion, the position of the tube-shaped member previously inserted into the lacrimal passage is inserted into the tube shape later. It can be confirmed from the lacrimal endoscope in the member, and it can be used as a guide to perform accurate insertion. Therefore, the formation of a temporary road can be prevented.
 前記着色部から他方端側のチューブ状部材の色については、色相環にて前記着色部の色相に対して補色色相または隣接補色色相となるように調整すればよく、例えば、黄、黄緑、緑等が挙げられる。 About the color of the tubular member on the other end side from the colored portion, it may be adjusted so that it becomes a complementary hue or an adjacent complementary hue with respect to the hue of the colored portion in the hue ring, for example, yellow, yellow-green, Examples include green.
 中でも、涙道内視鏡から確認し易いという観点から、着色部の色が青色であり、着色された他方端側のチューブ状部材の色が黄色であることが好ましい。 Among these, from the viewpoint of easy confirmation from the lacrimal endoscope, it is preferable that the color of the colored portion is blue and the color of the colored tubular member on the other end side is yellow.
 前記着色部は、金型を用いてのライン入りチューブ押出成形や、チューブ状部材の所望の位置に着色した中実チューブを熱溶着するなどの方法にて作製すればよく、作製方法は特に限定されない。 The colored part may be produced by a method such as line extrusion tube molding using a mold or heat welding a solid tube colored at a desired position of a tubular member, and the production method is particularly limited. Not.
 また、前記着色部から他方端側のチューブ状部材の着色は少なくとも1本のチューブ状部材に施されていればよいし、2本のチューブ状部材にそれぞれ施されていてもよい。2本のチューブ状部材に前記着色が施されている場合、それぞれの色は同じでも異なっていてもよい。 Moreover, the tube-shaped member on the other end side from the colored portion may be colored on at least one tube-shaped member, or may be applied to each of the two tube-shaped members. When the coloring is given to two tube-shaped members, each color may be the same or different.
 なお、2本のチューブ状部材に前記着色が施されていると、先に涙道内に挿入されているチューブ状部材の位置を後から挿入するチューブ状部材内から涙道内視鏡を通して確認した場合、鼻腔内面に対して先に留置されているチューブ状部材色が際立って見える。すなわち、暗い涙道内でもチューブ状部材の確認がより明確に行うことができ、後に留置するチューブ状部材の位置精度を高められる。さらに、2本のチューブ状部材に施されている色の種類によっては、前記チューブ状部材の末端部に着色部がなくとも使用することができる場合がある。このような色としては、黄、黄緑、緑等が挙げられる。 In addition, when the above-mentioned coloring is given to two tube-shaped members, when confirming the position of the tube-shaped member previously inserted in the lacrimal passage through the lacrimal endoscope from the inside of the tube-shaped member inserted later The color of the tubular member previously placed with respect to the inner surface of the nasal cavity is conspicuous. That is, the tubular member can be confirmed more clearly in the dark lacrimal passage, and the positional accuracy of the tubular member to be placed later can be increased. Furthermore, depending on the type of color applied to the two tube-shaped members, the tube-shaped member may be used even if there is no colored portion at the end. Examples of such colors include yellow, yellowish green, and green.
 なお、末端部が、無色透明ではなく、涙道内視鏡から末端部の壁部を通して外部の様子を観察できる程度に透明な材料(例えば、半透明の青色)にすることで、着色部を無くす場合もある。このようになっていても、例えば、2本のチューブ状部材に着色が施されている場合に、先に涙道内に挿入されているチューブ状部材の位置を後から挿入するチューブ状部材内から(例えば、末端部から)涙道内視鏡を通して確認することができるので、暗い涙道内でもチューブ状部材の確認がより明確に行うことができ、後に留置するチューブ状部材の位置精度を高められる。 In addition, the colored part is eliminated by making the end part not transparent and colorless, but by using a transparent material (for example, translucent blue) that allows the external appearance to be observed from the lacrimal endoscope through the wall of the end part. In some cases. Even in this case, for example, when the two tubular members are colored, the position of the tubular member previously inserted into the lacrimal passage is inserted later from within the tubular member. Since it can be confirmed through the lacrimal endoscope (for example, from the end portion), the tubular member can be more clearly confirmed even in the dark lacrimal passage, and the positional accuracy of the tubular member to be placed later can be improved.
 本発明の涙道チューブでは、前記チューブ状部材と前記接続部材とが接続される。前記接続部材は、2つのチューブ状部材の他方端同士を接続するためのものであり、チューブ状部材よりも小さい径であればよく、この径については特に限定はない。
 前記接続部材を構成する樹脂としては、柔軟な樹脂で構成されていればよく、例えば、シリコーン、ポリアミドエラストマー、ポリウレタン、イソブチレン系共重合体、およびこれらのアロイなどを含む樹脂組成物が挙げられるが、これらに限定されない。
In the lacrimal duct tube of the present invention, the tubular member and the connecting member are connected. The connecting member is for connecting the other ends of the two tubular members and may have a diameter smaller than that of the tubular member, and the diameter is not particularly limited.
The resin constituting the connecting member may be a flexible resin, and examples thereof include a resin composition containing silicone, polyamide elastomer, polyurethane, isobutylene copolymer, and alloys thereof. However, it is not limited to these.
 前記接続部材の長さとしては、市販の涙道チューブと同じ程度であればよく、特に限定はない。 The length of the connecting member is not particularly limited as long as it is about the same as a commercially available lacrimal duct tube.
 前記チューブ状部材と前記接続部材との接続の仕方としては、特に限定はない。例えば、前記チューブ状部材の他方端側の端部と前記接続部材の端部とが当接されていてもよいし、接続面がより大きく、接続箇所の強度がより高まる観点から、前記チューブ状部材の基端部の側面と前記接続部材の側面とで接続されていてもよい。 The way of connecting the tubular member and the connecting member is not particularly limited. For example, the end of the other end side of the tubular member and the end of the connecting member may be in contact with each other, or from the viewpoint of increasing the connecting surface and increasing the strength of the connecting portion, You may be connected by the side surface of the base end part of a member, and the side surface of the said connection member.
 また、本発明の涙道チューブは、涙道への挿入性や涙道内での操作性を優れたものとする観点から、前記チューブ状部材や接続部材の表面に親水性コーティングを施してもよい。 In addition, the lacrimal tube of the present invention may be provided with a hydrophilic coating on the surface of the tubular member or the connecting member from the viewpoint of excellent insertion into the lacrimal passage and operability in the lacrimal passage. .
 前記親水性コーティング部分に用いる親水性コーティングとは、血液や涙液と接触した際に潤滑性が発現し、涙道挿入時の抵抗が低減され、涙道内で好適な操作性を実現するためのものである。親水性コーティングの種類は特に限定されず、ポリ(2-ヒドロキシエチルメタクリレート)、ポリアクリルアミド、ポリビニルピロリドン、ポリアルキレングリコール、モノメトキシポリアルキレングリコール等の親水性ポリマー、またはこれらのブレンド等が好適に使用される。 The hydrophilic coating used for the hydrophilic coating portion expresses lubricity when it comes into contact with blood or tears, reduces resistance when the lacrimal passage is inserted, and realizes suitable operability in the lacrimal passage Is. The type of hydrophilic coating is not particularly limited, and hydrophilic polymers such as poly (2-hydroxyethyl methacrylate), polyacrylamide, polyvinyl pyrrolidone, polyalkylene glycol, monomethoxy polyalkylene glycol, or blends thereof are preferably used. Is done.
 本発明で用いられる涙道内視鏡としては、涙道閉塞治療に使用できるものであればよく、特に限定はない。
 また、本発明の涙道チューブを涙道内に挿入する際には、涙道内視鏡以外の涙道チューブ操作具を使用することもできる。このような涙道チューブ操作具としては、例えばブジーなどの操作棒が挙げられる。
The lacrimal endoscope used in the present invention is not particularly limited as long as it can be used for treatment of lacrimal passage obstruction.
In addition, when inserting the lacrimal tube of the present invention into the lacrimal passage, a lacrimal tube operating tool other than the lacrimal endoscope can be used. As such a lacrimal duct tube operating tool, for example, an operating rod such as a bougie is cited.
 以下に本発明に係る涙道チューブを図面に示した複数の実施形態に基づき説明するが、本発明はこれらの実施態様により何ら制限されるものではない。 Hereinafter, the lacrimal duct tube according to the present invention will be described based on a plurality of embodiments shown in the drawings, but the present invention is not limited to these embodiments.
 図4(a)、(b)、(c)は、本発明の涙道チューブ1の外観の一例を示したものである。図4(a)は涙道チューブ1の斜視図、図4(b)は涙道チューブ1の側面図、図4(c)は涙道チューブ1の上面図を示す。 4 (a), 4 (b), and 4 (c) show an example of the appearance of the lacrimal duct tube 1 of the present invention. 4A is a perspective view of the lacrimal tube 1, FIG. 4B is a side view of the lacrimal tube 1, and FIG. 4C is a top view of the lacrimal tube 1.
 涙道チューブ1は、一対のチューブ状部材2と、これらチューブ状部材2の端同士をつなぐ接続部材3とを含む涙道チューブである。
 前記チューブ状部材2はいずれも一方端(先端)4に開口部5を有しており、開口部5は内腔6へ連通している。また、一対の前記チューブ状部材2はいずれも他方端側7で接続部材3と接続している。
The lacrimal duct tube 1 is a lacrimal duct tube including a pair of tubular members 2 and a connecting member 3 that connects the ends of the tubular members 2.
Each of the tubular members 2 has an opening 5 at one end (tip) 4, and the opening 5 communicates with the lumen 6. The pair of tubular members 2 are both connected to the connecting member 3 on the other end side 7.
 前記チューブ状部材2は、図4(c)に示すように、一方端4から他方端7にかけて、末端部8、本体9および基端部10から構成されており、基端部10に出入口11を有している。 As shown in FIG. 4C, the tubular member 2 is composed of a distal end portion 8, a main body 9, and a proximal end portion 10 from one end 4 to the other end 7. have.
 涙道チューブ1では、少なくとも一方の前記チューブ状部材2における一方端4を含む末端部8が無色材料で形成されている。 In the lacrimal duct tube 1, at least one end portion 8 including the one end 4 of the tubular member 2 is formed of a colorless material.
 前記末端部8の全長の範囲については特に限定はなく、一方端4から2~10mmの範囲であればよい。 The total length of the end portion 8 is not particularly limited, and may be in the range of 2 to 10 mm from the one end 4.
 また、本発明の涙道チューブでは、前記無色材料で形成される前記末端部8の周囲の一部に、前記チューブ状部材の長軸方向に沿う着色部(ライン)12が形成されている。なお、図4(a)では、着色部12は、チューブ状部材の周囲方向に対して出入口11の反対側に設けられているため、図4(b)の側面図では見えない位置にある。 Further, in the lacrimal duct tube of the present invention, a colored portion (line) 12 is formed along the long axis direction of the tubular member around a part of the end portion 8 formed of the colorless material. In FIG. 4 (a), the colored portion 12 is provided on the opposite side of the entrance / exit 11 with respect to the circumferential direction of the tubular member, and therefore is in a position that cannot be seen in the side view of FIG. 4 (b).
 前記着色部12は、図4(a)、(c)に示すように、チューブ状部材2の一方端4まで形成されていてもよいし、より短くてもよい。 The colored portion 12 may be formed up to one end 4 of the tubular member 2 as shown in FIGS. 4A and 4C, or may be shorter.
 前記着色部12の形状については、図4(a)、(c)に示すように、一連状の線でもよいし、図5(a)、(b)に示すように、破線でもよい。なお、図5(b)は、図5(a)のチューブ状部材2の末端部8付近の拡大図である。 The shape of the colored portion 12 may be a series of lines as shown in FIGS. 4 (a) and 4 (c), or may be a broken line as shown in FIGS. 5 (a) and 5 (b). FIG. 5B is an enlarged view of the vicinity of the end portion 8 of the tubular member 2 of FIG.
 前記着色部12の幅としては、前記末端部8の周囲全長に対して1/50以上1/3以下の長さの幅であればよい。例えば、図6(a)、(b)に示すように、末端部8の周囲全長に対して1/3の長さの幅にしても、着色部12以外の透明な壁部を通して涙道内の確認はできる。なお、図6(b)は、図6(a)のチューブ状部材2の末端部8付近の拡大図である。 The width of the colored portion 12 may be a width of 1/50 or more and 1/3 or less with respect to the entire peripheral length of the end portion 8. For example, as shown in FIGS. 6 (a) and 6 (b), even if the width is 1/3 of the entire peripheral length of the end portion 8, the inside of the lacrimal passage through the transparent wall portion other than the colored portion 12 is used. Confirmation is possible. In addition, FIG.6 (b) is an enlarged view of the terminal part 8 vicinity of the tubular member 2 of Fig.6 (a).
 また、前記着色部12は、前記チューブ状部材2の周囲方向における出入口11の位置と同じ側および反対側の少なくとも一方側に形成されていてもよい。例えば、チューブ状部材2の基端部10や本体9の直交断面の中心に対して偏心した、基端部10のテーパー形状の最も細い部分の箇所(他方端7)の位置を、出入口11の位置の反対側としてもよい。
 具体的には、図4(a)、(c)に示す涙道チューブ1では、着色部12は、チューブ状部材2の周囲方向における出入口11の位置と反対側に形成されている。また、図4(a)、(c)において着色部12の位置が長軸方向に対する直交断面方向にて、末端部8を境に反対側に変えた場合には、図示しないが、その着色部12は、チューブ状部材2の周囲方向における出入口11の位置と同じ側に形成されていることになる。
 また、図7(a)、(b)に示すようにチューブ状部材2の周囲方向における出入口11の位置と同じ側および反対側に着色部12a、12bが2つ形成されていてもよい。この場合について、例えば、図8に示すように、出入口11の位置と同じ側の着色部12aの幅は、出入口11の位置と反対側の着色部12bの幅と、異なっていることが好ましい(ただし、これに限定されず、異なる幅を有する着色部12aと12bの配置が逆になっていてもよいし、同幅の着色部12a、12bが形成されていてもよい。)。このようになっていると、末端部8が涙道内の閉塞部や狭窄部を穿破する際に大きく変形した上、材質の透明性から涙道内視鏡で把握しにくくなったとしても、2本の着色部12a、12bにより、末端部8の変形状態が立体的に把握され、開口部5の位置を涙道内視鏡で把握でき、ひいては涙道内視鏡の先端位置を把握できる。また、幅長を異とする着色部12a、12bと出入口11との位置関係より、涙道チューブの向きも把握できる。これらによって、正確な涙道チューブ挿入術を行える。
The colored portion 12 may be formed on the same side as the position of the entrance / exit 11 in the circumferential direction of the tubular member 2 and on at least one side opposite to the side. For example, the position of the narrowest portion (the other end 7) of the tapered shape of the base end portion 10 which is eccentric with respect to the center of the base end portion 10 of the tubular member 2 or the main body 9 is the position of the entrance / exit 11. It may be on the opposite side of the position.
Specifically, in the lacrimal duct tube 1 shown in FIGS. 4A and 4C, the colored portion 12 is formed on the side opposite to the position of the entrance / exit 11 in the circumferential direction of the tubular member 2. Further, in FIGS. 4A and 4C, when the position of the colored portion 12 is changed to the opposite side with respect to the end portion 8 in the cross-sectional direction orthogonal to the major axis direction, the colored portion is not shown. 12 is formed on the same side as the position of the entrance / exit 11 in the circumferential direction of the tubular member 2.
Moreover, as shown to Fig.7 (a), (b), the two colored parts 12a and 12b may be formed in the same side as the position of the entrance / exit 11 in the circumferential direction of the tubular member 2, and an opposite side. In this case, for example, as shown in FIG. 8, the width of the colored portion 12a on the same side as the position of the entrance / exit 11 is preferably different from the width of the colored portion 12b on the side opposite to the position of the entrance / exit 11 ( However, the present invention is not limited to this, and the arrangement of the colored portions 12a and 12b having different widths may be reversed, or the colored portions 12a and 12b having the same width may be formed. Even if it becomes difficult to grasp | ascertain with the lacrimal duct endoscope from the transparency of a material, since the terminal part 8 deform | transforms greatly at the time of piercing the obstruction | occlusion part and stenosis part in a lacrimal passage when it has become like this, 2 By the coloring portions 12a and 12b of the book, the deformation state of the end portion 8 can be grasped three-dimensionally, the position of the opening 5 can be grasped by the lacrimal endoscope, and the tip position of the lacrimal endoscope can be grasped. Further, the orientation of the lacrimal tube can also be grasped from the positional relationship between the colored portions 12a and 12b having different widths and the entrance / exit 11. These allow accurate lacrimal tube insertion.
 また、一方のチューブ状部材2において、前記着色部12よりも他方端側のチューブ状部材2の全周囲に別の着色した部分13が設けられている。
 前記着色した部分13は、図4(a)~(c)に示すように、少なくともチューブ状部材2の本体9に形成していればよいが、さらに基端部10にも形成してもよい。
 前記着色した部分13は、チューブ状部材2の一方にあればよい。また、図9(a)、(c)に示す涙道チューブ1のように両方のチューブ状部材2に着色した部分13を施してもよい。なお、図9(a)~(c)に示す涙道チューブ1の構成は、前記着色した部分13が2つある以外は、図4(a)~(c)に示す涙道チューブ1の構成と同じである。
Further, in one tubular member 2, another colored portion 13 is provided around the entire circumference of the tubular member 2 on the other end side from the colored portion 12.
The colored portion 13 may be formed at least on the main body 9 of the tubular member 2 as shown in FIGS. 4 (a) to 4 (c), but may also be formed on the base end portion 10. .
The colored portion 13 may be on one side of the tubular member 2. Moreover, you may give the colored part 13 to both the tubular members 2 like the lacrimal duct tube 1 shown to Fig.9 (a), (c). The lacrimal tube 1 shown in FIGS. 9 (a) to 9 (c) has the same configuration as the lacrimal tube 1 shown in FIGS. 4 (a) to 4 (c) except that the two colored portions 13 are provided. Is the same.
 前記着色した部分13の色相は、色相環にて、前記着色部12の色相に対して補色色相または隣接補色色相である。
 中でも、前記着色した部分13の色が黄色であり、前記着色部12の色が青色であることで、暗い涙道内でチューブ状部材2の位置を確認し易くなるため好ましい。
 また、図9(a)、(c)に示す涙道チューブ1のように、2本のチューブ状部材2にそれぞれ着色した部分13が施されている場合、一方の着色した部分13の色を黄、黄緑または緑にし、他方の着色した部分13の色を前記の色と同じ色または異なる色にしてもよい。
The hue of the colored portion 13 is a complementary hue or an adjacent complementary hue with respect to the hue of the colored portion 12 in a hue circle.
Especially, since the color of the colored portion 13 is yellow and the color of the colored portion 12 is blue, the position of the tubular member 2 can be easily confirmed in the dark lacrimal passage.
Moreover, when the colored part 13 is given to the two tubular members 2 like the lacrimal duct tube 1 shown to FIG. 9 (a), (c), the color of one colored part 13 is changed. Yellow, yellow-green, or green may be used, and the color of the other colored portion 13 may be the same as or different from the color described above.
 なお、本発明の涙道チューブ1において、前記出入口11は、図4(a)、図5(a)、図6(a)に示すようにチューブ状部材の他方端側の末端に設けている以外に、チューブ状部材2の壁部に設けてもよい。例えば、図4(c)のチューブ状部材2の本体9の任意の壁部に孔を設けてもよい(図示せず)。前記孔の形状については特に限定はないが、楕円形状が好ましい。
 また、図5(a)、図6(a)、図7(a)に示す涙道チューブ1では、いずれも一方のチューブ状部材2に着色した部分13を施しているが、図9(a)と同様に、両方のチューブ状部材2に着色した部分13を施していてもよい。また、2本のチューブ状部材2にそれぞれ着色した部分13が施されている場合、一方の着色した部分13の色を黄、黄緑または緑にし、他方の着色した部分13の色を前記の色と同じ色または異なる色にしてもよい。
In the lacrimal duct tube 1 of the present invention, the entrance / exit 11 is provided at the end on the other end side of the tubular member as shown in FIGS. 4 (a), 5 (a), and 6 (a). In addition, you may provide in the wall part of the tubular member 2. FIG. For example, you may provide a hole in the arbitrary wall part of the main body 9 of the tubular member 2 of FIG.4 (c) (not shown). The shape of the hole is not particularly limited, but an elliptical shape is preferable.
Moreover, in the lacrimal duct tube 1 shown to Fig.5 (a), FIG.6 (a), and Fig.7 (a), all have given the colored part 13 to one tubular member 2, but FIG. ), Colored portions 13 may be applied to both tubular members 2. Further, when the colored portions 13 are respectively provided on the two tubular members 2, the color of one colored portion 13 is set to yellow, yellowish green, or green, and the color of the other colored portion 13 is set to the above-described color. The color may be the same color or a different color.
(実施例1)
 チューブ状部材の末端部が単層、本体が4層の積層構造を有する涙道チューブを以下のようにして作製した。
 まず、末端部が単層で、本体が4層構造を有するチューブの他方端に、同径のポリウレタン製の基端部用チューブを当接し、その基端部用チューブの側面に、接続部材用のロッドの側面を接続し、前記当接面よりも一方端側にまでロッドの先端の位置がくるように調整して、各部の接続箇所を一度に熱溶着した。
 次いで、基端部の一方端側付近から他方端側付近までを斜めカットして出入口を形成することで、図4(a)~(c)に示す外観を有する、一対のチューブ状部材および接続部材を有する涙道チューブを作製した。
Example 1
A lacrimal tube having a laminated structure in which the end portion of the tubular member has a single layer and the main body has a four-layer structure was produced as follows.
First, a base end tube made of polyurethane having the same diameter is brought into contact with the other end of a tube having a single layer and a main body having a four-layer structure. The rod side surfaces were connected and adjusted so that the position of the tip of the rod would be closer to one end side than the abutting surface, and the connection locations of each part were thermally welded at once.
Next, a pair of tubular members and connections having the appearance shown in FIGS. 4 (a) to 4 (c) are formed by obliquely cutting the vicinity of one end side to the other end side of the base end portion to form an entrance / exit. A lacrimal tube having a member was prepared.
 使用した各部材の構成は以下のとおり。
(チューブ状部材)
(1)末端部
 低密度ポリエチレン製
 末端部長さ:約4mm、直径:0.9~1.3mmの先細のテーパー形状
 
(2)本体
 最内層(第1層):低密度ポリエチレン製、内側中間層(第2層):高密度ポリエチレン製、外側中間層(第3層):接着性低密度ポリエチレン製、最外層(第4層):ポリウレタン製
 内腔の直径:0.96mm
 
 また、チューブ状部材の末端部と本体は、内腔からも涙道内視鏡で観察できる程度に透明な状態であった。
 
(3)基端部
 ポリウレタン製
 内径:0.96mm、長さ:5mm
 
(接続部材)
 ポリウレタン製
 直径:0.7mm
 全長:23mm
The structure of each member used is as follows.
(Tube-shaped member)
(1) Terminal part Low-density polyethylene terminal part length: approx. 4mm, diameter: 0.9-1.3mm taper taper
(2) Main body Innermost layer (first layer): made of low-density polyethylene, inner intermediate layer (second layer): made of high-density polyethylene, outer intermediate layer (third layer): made of adhesive low-density polyethylene, outermost layer ( (Fourth layer): Made of polyurethane Lumen diameter: 0.96 mm

Further, the distal end portion and the main body of the tubular member were in a transparent state so that they could be observed with a lacrimal endoscope from the lumen.

(3) Base end made of polyurethane Inner diameter: 0.96 mm, Length: 5 mm

(Connecting member)
Diameter of polyurethane: 0.7mm
Total length: 23mm
 次いで、得られた涙道チューブにある2本のチューブ状部材2において、接続部材3のロッドの接続面と同じ側(基端部10の出入口11の位置と反対側)の末端部8に一方端まで形成された青色の着色部12を設けた。着色部12は一連状の線で、末端部の周囲全長に対して1/10の長さの幅に調整した。
 また、一方のチューブ状部材では、着色部12から他方端側の本体9の全周囲を黄色に着色した。
Subsequently, in the two tubular members 2 in the obtained lacrimal tube, one end is placed on the end portion 8 on the same side as the connecting surface of the rod of the connecting member 3 (the side opposite to the position of the entrance / exit 11 of the base end portion 10). A blue colored portion 12 formed to the end was provided. The colored portion 12 was a series of lines, and was adjusted to a width of 1/10 of the total length around the end portion.
Further, in one tubular member, the entire periphery of the main body 9 on the other end side from the colored portion 12 was colored yellow.
(試験例1)
 実施例1で得られた涙道チューブを使用してSEPと同様の挿入術により実際の涙道に涙道チューブを留置した。
 まず、黄色に着色したチューブ状部材の基端部の出入口から開口部付近まで涙道内視鏡のプローブを挿入して装着した後、実際の涙道の上涙点から上涙点小管を通過して下鼻道まで涙道チューブを挿入していった。涙道内の様子は、涙道チューブのチューブ状部材の開口部から観察して把握することができ、また挿入する際には、チューブ状部材の着色部の向きを確認することで方向を間違えずに閉塞部などの目的の場所に確実に挿入することができた。下鼻道から涙道チューブの先が出たことを確認した後、涙道内視鏡を取り外して涙道チューブを涙道内に留置した。
 続いて、透明なチューブ状部材の基端部の出入口から開口部付近まで涙道内視鏡のプローブを挿入して装着した後、涙道の下涙点から下涙点小管を通過して挿入していった。真っ暗な涙嚢および鼻涙管においても、先に挿入したチューブ状部材の位置は、黄色の着色部分を見つけることで簡単に把握できた。また、黄色の着色部の方向を確認することで挿入すべき下鼻道の位置も簡単に把握できた。
(Test Example 1)
Using the lacrimal tube obtained in Example 1, the lacrimal tube was placed in the actual lacrimal passage by the same insertion method as SEP.
First, after inserting the probe of the lacrimal endoscope from the entrance and exit of the base end of the tube-shaped member colored yellow to the vicinity of the opening, it passes through the upper punctum canal from the upper punctum of the actual lacrimal passage. The lacrimal tube was inserted into the lower nasal passage. The inside of the lacrimal passage can be grasped by observing from the opening of the tubular member of the lacrimal tube, and when inserting, the direction of the colored portion of the tubular member can be confirmed without making a mistake in the direction. It was possible to insert it securely into the target place such as a closed part. After confirming that the tip of the lacrimal tube came out from the lower nasal passage, the lacrimal endoscope was removed and the lacrimal tube was placed in the lacrimal passage.
Next, after inserting the probe of the lacrimal endoscope from the entrance / exit of the base end of the transparent tubular member to the vicinity of the opening, and then inserting the probe from the lower punctum of the lacrimal passage through the lower punctum tubule. I went. Even in the dark lacrimal sac and nasolacrimal duct, the position of the previously inserted tubular member could be easily grasped by finding the yellow colored portion. Moreover, the position of the lower nasal passage to be inserted could be easily grasped by confirming the direction of the yellow colored portion.
(試験例2)
 実施例1で得られた涙道チューブにある2本のチューブ状部材2において、基端部10の出入口11の位置と同じ側および反対側の末端部8の表面に、図7(a)、(b)に示すように、それぞれ一方端4まで形成された一連状で青色の着色部12a、12bを設けた。なお、図8に示すように、出入口11と同じ側の着色部12aの幅は、出入口11と反対側の着色部12bの幅に比べて狭くなるように調整した。これ以外の構成は、試験例1と同じようにした。
(Test Example 2)
In the two tubular members 2 in the lacrimal duct obtained in Example 1, on the same side as the position of the entrance / exit 11 of the proximal end 10 and the surface of the distal end 8 on the opposite side, FIG. As shown in (b), blue colored portions 12a and 12b were provided in a series of shapes each formed up to one end 4. In addition, as shown in FIG. 8, the width of the colored portion 12a on the same side as the entrance / exit 11 was adjusted to be narrower than the width of the colored portion 12b on the side opposite to the entrance / exit 11. The other configuration was the same as in Test Example 1.
 試験例1と同様に、着色した涙道チューブを使用してSEPと同様の挿入術により実際の涙道に涙道チューブを留置した。涙道内の閉塞部を穿破する際、末端部が大きく変形したが、末端における円周方向にて対角関係に2本の着色部が存在することで、末端部の変形状態、かつ、開口部と涙道内視鏡との位置関係を正確に把握しながら挿入術を行うことができた。また、2本の着色部のうち、出入口11と同じ側の着色部の幅を細くしていることから、涙道チューブの向きを確認することができ、方向を間違えずに目的の場所に確実に挿入することができた。 In the same manner as in Test Example 1, the lacrimal duct tube was placed in the actual lacrimal passage by using the colored lacrimal duct tube by the same insertion method as SEP. When piercing the occlusion part in the lacrimal passage, the end part was greatly deformed, but the presence of two colored parts in a diagonal relationship in the circumferential direction at the end makes the end part deformed and the opening Insertion was performed while accurately grasping the positional relationship between the head and lacrimal endoscope. Moreover, since the width of the colored portion on the same side as the entrance / exit 11 of the two colored portions is narrowed, the direction of the lacrimal tube can be confirmed, and the direction of the lacrimal tube can be confirmed without mistake in the direction. Could be inserted into.
 1 涙道チューブ
 2 チューブ状部材
 3 接続部材
 4 一方端
 5 開口部
 6 内腔
 7 他方端
 8 末端部
 9 本体
 10 基端部
 11 出入口
 12 着色部
 13 着色部12よりも他方端側の着色した部分
 21 上涙点
 22 下涙点
 23 上涙小管
 24 下涙小管
 25 総涙小管
 26 涙嚢
 27 鼻涙管
 28 下鼻道
 29 涙道内視鏡
 30 シース
 31 涙道
 32 閉塞部位
 33 涙道チューブ
DESCRIPTION OF SYMBOLS 1 Lacrimal duct tube 2 Tubular member 3 Connection member 4 One end 5 Opening part 6 Lumen 7 Other end 8 Terminal part 9 Main body 10 Base end part 11 Entrance / exit 12 Colored part 13 Colored part on the other end side than the colored part 12 DESCRIPTION OF SYMBOLS 21 Upper punctum 22 Lower punctum 23 Upper lacrimal duct 24 Lower lacrimal duct 25 Total lacrimal duct 26 Lacrimal sac 27 Nasal lacrimal duct 28 Lower nasal passage 29 Lacrimal endoscope 30 Sheath 31 Lacrimal duct 32 Occlusion site 33 Lacrimal duct tube

Claims (8)

  1.  一方端に内腔へ連通する開口部を有する一対のチューブ状部材と、これらチューブ状部材の他方端同士をつなぐ接続部材と、を含む涙道チューブであって、
     少なくとも一方の前記チューブ状部材における一方端を含む末端部が無色材料で形成され、
     前記無色材料で形成される前記末端部の周囲の一部に、前記チューブ状部材の長軸方向に沿う着色部が形成され、
     一対の前記チューブ状部材の一方のチューブ状部材の色相が、色相環にて、前記着色部の色相に対して補色色相または隣接補色色相であること
    を特徴とする涙道チューブ。
    A lacrimal duct tube comprising a pair of tubular members having an opening communicating with the lumen at one end, and a connecting member connecting the other ends of these tubular members,
    A terminal portion including one end of at least one of the tubular members is formed of a colorless material,
    A colored portion along the longitudinal direction of the tubular member is formed on a part of the periphery of the end portion formed of the colorless material,
    A lacrimal duct tube, wherein a hue of one tube-shaped member of the pair of tube-shaped members is a complementary color hue or an adjacent complementary color hue with respect to the hue of the colored portion in a hue ring.
  2.  前記着色部が前記一方端にまで形成されている請求項1に記載の涙道チューブ。 The lacrimal duct tube according to claim 1, wherein the colored portion is formed up to the one end.
  3.  前記着色部が一連状の線または破線である請求項1または2に記載の涙道チューブ。 The lacrimal duct tube according to claim 1 or 2, wherein the colored portion is a series of lines or broken lines.
  4.  前記着色部が前記末端部の周囲全長に対する1/50以上1/3以下の長さの幅を有する請求項1~3のいずれか1項に記載の涙道チューブ。 The lacrimal duct tube according to any one of claims 1 to 3, wherein the colored portion has a width of 1/50 or more and 1/3 or less of the entire peripheral length of the end portion.
  5.  前記チューブ状部材における前記着色部が、前記チューブ状部材の周囲方向における、チューブ状部材の他方端側にある出入口の位置と同じ側および反対側の少なくとも一方側に形成されている請求項1~4のいずれか1項に記載の涙道チューブ。 The colored portion of the tubular member is formed on at least one side opposite to the same side as the position of the entrance / exit on the other end side of the tubular member in the circumferential direction of the tubular member. The lacrimal duct tube according to any one of 4.
  6.  前記着色部が前記チューブ状部材の周囲方向における出入口の位置と同じ側および反対側に形成されており、一方の着色部の幅が他方の着色部の幅と異なるように形成されている請求項5に記載の涙道チューブ。 The colored portion is formed on the same side and the opposite side as the position of the entrance / exit in the circumferential direction of the tubular member, and the width of one colored portion is formed different from the width of the other colored portion. 5. The lacrimal duct tube according to 5.
  7.  幅の細い前記着色部が、前記チューブ状部材の周囲方向における出入口の位置と同じ側に形成され、幅の太い前記着色部が、反対側に形成されている請求項6に記載の涙道チューブ。 The lacrimal duct tube according to claim 6, wherein the narrow colored portion is formed on the same side as the position of the entrance / exit in the circumferential direction of the tubular member, and the thick colored portion is formed on the opposite side. .
  8.  着色された前記チューブ状部材の色が黄色であり、前記着色部の色が青色である請求項1~7のいずれかに記載の涙道チューブ。
     
     
    The lacrimal duct tube according to any one of claims 1 to 7, wherein the colored tubular member is yellow and the colored portion is blue.

PCT/JP2015/051275 2014-01-22 2015-01-19 Tear duct tube WO2015111554A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015558846A JP6581909B2 (en) 2014-01-22 2015-01-19 Lacrimal tube

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014-009689 2014-01-22
JP2014009689 2014-01-22

Publications (1)

Publication Number Publication Date
WO2015111554A1 true WO2015111554A1 (en) 2015-07-30

Family

ID=53681358

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2015/051275 WO2015111554A1 (en) 2014-01-22 2015-01-19 Tear duct tube

Country Status (2)

Country Link
JP (1) JP6581909B2 (en)
WO (1) WO2015111554A1 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5437625A (en) * 1992-04-06 1995-08-01 Kurihashi; Katsuaki Apparatus for intubation of lacrimal drainage pathway
US6113567A (en) * 1995-10-25 2000-09-05 Becker; Bruce B. Lacrimal silicone tube with reduced friction
JP2005013698A (en) * 2003-06-28 2005-01-20 M L C:Kk Lacrimal duct intubation appliance
JP2006181054A (en) * 2004-12-27 2006-07-13 Sugimoto Ganka Iin Intubating equipment to lacrimal duct
JP2007313290A (en) * 2006-04-27 2007-12-06 Sugimoto Ganka Iin Lacrimal passage treatment instrument
JP2011200601A (en) * 2010-03-26 2011-10-13 Kaneka Corp Lacrimal duct tube
JP2011200600A (en) * 2010-03-26 2011-10-13 Kaneka Corp Lacrimal duct tube
CN102697582A (en) * 2012-05-23 2012-10-03 中山市人民医院 Lacrimal passage device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4382401B2 (en) * 2003-06-27 2009-12-16 株式会社カネカ Thermoplastic resin composition
US20120215153A1 (en) * 2009-10-22 2012-08-23 Kohei Fukaya Tube device for insertion into lacrimal passage

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5437625A (en) * 1992-04-06 1995-08-01 Kurihashi; Katsuaki Apparatus for intubation of lacrimal drainage pathway
US6113567A (en) * 1995-10-25 2000-09-05 Becker; Bruce B. Lacrimal silicone tube with reduced friction
JP2005013698A (en) * 2003-06-28 2005-01-20 M L C:Kk Lacrimal duct intubation appliance
JP2006181054A (en) * 2004-12-27 2006-07-13 Sugimoto Ganka Iin Intubating equipment to lacrimal duct
JP2007313290A (en) * 2006-04-27 2007-12-06 Sugimoto Ganka Iin Lacrimal passage treatment instrument
JP2011200601A (en) * 2010-03-26 2011-10-13 Kaneka Corp Lacrimal duct tube
JP2011200600A (en) * 2010-03-26 2011-10-13 Kaneka Corp Lacrimal duct tube
CN102697582A (en) * 2012-05-23 2012-10-03 中山市人民医院 Lacrimal passage device

Also Published As

Publication number Publication date
JPWO2015111554A1 (en) 2017-03-23
JP6581909B2 (en) 2019-09-25

Similar Documents

Publication Publication Date Title
US8449527B2 (en) Splittable cannula having radiopaque marker
EP3777952B1 (en) Balloon catheter visualization systems
US9668719B2 (en) Vascular closure devices comprising force management features and related methods
DE112011105242T5 (en) deployment catheter
US10058451B2 (en) Lacrimal duct tube
JP5999109B2 (en) Lacrimal tube
JP6616924B2 (en) Lacrimal tube
EP3322373A1 (en) Lighted gastric medical device assembly and method
JP3748994B2 (en) Endoscope fitting
WO2011049198A1 (en) Tube device for insertion into lacrimal passage
JP6152851B2 (en) Lacrimal tube
JP6581909B2 (en) Lacrimal tube
JP7370990B2 (en) Ophthalmic microsurgical instruments
US10070991B2 (en) Lacrimal duct tube
US20210275354A1 (en) Lacrimal intubation system
JP6115475B2 (en) Lacrimal intubation device
WO2013190666A1 (en) Puncture instrument
TR201514424A2 (en) MANUAL PROXIMAL ANASTOMOSIS DEVICE FOR CORONARY BYPASS SURGERY

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15739819

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2015558846

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15739819

Country of ref document: EP

Kind code of ref document: A1